EXPERIMENTAL FACTOR ONTOLOGY - ANNOTATIONS |
|
|
Term: | gonadal disorder |
|
Accession: | EFO:MONDO:0002259
|
browse the term
|
Definition: | A non-neoplastic or neoplastic disorder that affects the testis or the ovary. |
Synonyms: | exact_synonym: | disease of gonad; disease or disorder of gonad; disorder of gonad; disorder of gonads; gonad disease; gonad disease or disorder; gonadal disorders |
| alt_id: | MONDO:0002259 |
| xref: | DOID:2277; MEDGEN:9074; MESH:D006058; NCI:C26786; UMLS:C0018050 |
| external_ontology: | disease_has_location EFO:UBERON:0000991 |
|
|
|
Q
|
GWAS1199466_H
|
amenorrhea, response to antineoplastic agent QTL GWAS1199466 (human)
|
|
IAGP
|
rs147451859
| 6.0E-9 |
|
|
GWAS_CATALOG |
PMID:31371054 |
|
NCBI chr15:75,039,102...75,039,103
|
|
Q
|
GWAS1199697_H
|
amenorrhea, response to antineoplastic agent QTL GWAS1199697 (human)
|
|
IAGP
|
rs6488809
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:31371054 |
|
NCBI chr12:16,001,304...16,001,305
|
|
Q
|
GWAS1199698_H
|
amenorrhea, response to antineoplastic agent QTL GWAS1199698 (human)
|
|
IAGP
|
rs1410669
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:31371054 |
|
NCBI chr 6:71,740,732...71,740,733
|
|
Q
|
GWAS1199699_H
|
amenorrhea, response to antineoplastic agent QTL GWAS1199699 (human)
|
|
IAGP
|
rs11096688
| 7.0E-7 |
|
|
GWAS_CATALOG |
PMID:31371054 |
|
NCBI chr 2:20,885,650...20,885,651
|
|
Q
|
GWAS1199700_H
|
amenorrhea, response to antineoplastic agent QTL GWAS1199700 (human)
|
|
IAGP
|
rs73419340
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:31371054 |
|
NCBI chr 7:93,388,705...93,388,706
|
|
Q
|
GWAS1199701_H
|
amenorrhea, response to antineoplastic agent QTL GWAS1199701 (human)
|
|
IAGP
|
rs78264913
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:31371054 |
|
NCBI chr12:29,733,920...29,733,921
|
|
Q
|
GWAS1566484_H
|
amenorrhea, response to antineoplastic agent QTL GWAS1566484 (human)
|
|
IAGP
|
rs17587029
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:31371054 |
|
NCBI chr 2:112,624,477...112,624,478
|
|
Q
|
GWAS1566485_H
|
amenorrhea, response to antineoplastic agent QTL GWAS1566485 (human)
|
|
IAGP
|
rs1189020
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:31371054 |
|
NCBI chr14:56,410,241...56,410,242
|
|
Q
|
GWAS1566486_H
|
amenorrhea, response to antineoplastic agent QTL GWAS1566486 (human)
|
|
IAGP
|
rs77569618
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:31371054 |
|
NCBI chr 5:6,784,082...6,784,083
|
|
Q
|
GWAS1566487_H
|
amenorrhea, response to antineoplastic agent QTL GWAS1566487 (human)
|
|
IAGP
|
rs1119997
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:31371054 |
|
NCBI chr 8:131,109,670...131,109,671
|
|
Q
|
GWAS1822716_H
|
amenorrhea QTL GWAS1822716 (human)
|
|
IAGP
|
rs11031002
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
|
Q
|
GWAS1346322_H
|
Central precocious puberty QTL GWAS1346322 (human)
|
|
IAGP
|
rs4654084
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr 1:245,760,413...245,760,414
|
|
Q
|
GWAS1346323_H
|
Central precocious puberty QTL GWAS1346323 (human)
|
|
IAGP
|
rs118156955
| 7.0E-7 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr 2:222,131,550...222,131,551
|
|
Q
|
GWAS1346324_H
|
Central precocious puberty QTL GWAS1346324 (human)
|
|
IAGP
|
rs11130329
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr 3:52,862,839...52,862,840
|
|
Q
|
GWAS1346325_H
|
Central precocious puberty QTL GWAS1346325 (human)
|
|
IAGP
|
rs4543136
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr 4:145,972,800...145,972,801
|
|
Q
|
GWAS1346326_H
|
Central precocious puberty QTL GWAS1346326 (human)
|
|
IAGP
|
rs2347637
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr 6:151,707,344...151,707,345
|
|
Q
|
GWAS1346488_H
|
Central precocious puberty QTL GWAS1346488 (human)
|
|
IAGP
|
rs56810982
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr10:6,554,370...6,554,371
|
|
Q
|
GWAS1346489_H
|
Central precocious puberty QTL GWAS1346489 (human)
|
|
IAGP
|
rs77000039
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr11:112,808,338...112,808,339
|
|
Q
|
GWAS1520305_H
|
Central precocious puberty QTL GWAS1520305 (human)
|
|
IAGP
|
rs56698321
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr 1:67,205,695...67,205,696
|
|
Q
|
GWAS1520306_H
|
Central precocious puberty QTL GWAS1520306 (human)
|
|
IAGP
|
rs1024889
| 7.0E-22 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr 3:70,414,179...70,414,180
|
|
Q
|
GWAS1520307_H
|
Central precocious puberty QTL GWAS1520307 (human)
|
|
IAGP
|
rs9997440
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr 4:31,206,989...31,206,990
|
|
Q
|
GWAS1520308_H
|
Central precocious puberty QTL GWAS1520308 (human)
|
|
IAGP
|
rs12662085
| 6.0E-8 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr 6:9,894,200...9,894,201
|
|
Q
|
GWAS1520309_H
|
Central precocious puberty QTL GWAS1520309 (human)
|
|
IAGP
|
rs76540613
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr 8:125,761,515...125,761,516
|
|
Q
|
GWAS1520615_H
|
Central precocious puberty QTL GWAS1520615 (human)
|
|
IAGP
|
rs7851008
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr 9:79,981,586...79,981,587
|
|
Q
|
GWAS1520616_H
|
Central precocious puberty QTL GWAS1520616 (human)
|
|
IAGP
|
rs117195585
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:34288885 |
|
NCBI chr12:45,147,536...45,147,537
|
|
|
Q
|
GWAS1428997_H
|
high grade ovarian serous adenocarcinoma QTL GWAS1428997 (human)
|
|
IAGP
|
rs10069690
| 1.0E-19 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 5:1,279,675...1,279,676
|
|
Q
|
GWAS1428998_H
|
high grade ovarian serous adenocarcinoma QTL GWAS1428998 (human)
|
|
IAGP
|
rs10810671
| 7.0E-10 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 9:16,914,837...16,914,838
|
|
Q
|
GWAS1428999_H
|
high grade ovarian serous adenocarcinoma QTL GWAS1428999 (human)
|
|
IAGP
|
rs4149419
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 4:69,726,524...69,726,525
|
|
Q
|
GWAS1429001_H
|
high grade ovarian serous adenocarcinoma QTL GWAS1429001 (human)
|
|
IAGP
|
rs7851336
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 9:19,030,885...19,030,886
|
|
Q
|
GWAS1615683_H
|
high grade ovarian serous adenocarcinoma QTL GWAS1615683 (human)
|
|
IAGP
|
rs895412
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 2:113,216,387...113,216,388
|
|
Q
|
GWAS1633771_H
|
high grade ovarian serous adenocarcinoma QTL GWAS1633771 (human)
|
|
IAGP
|
rs12982058
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr19:17,298,571...17,298,572
|
|
Q
|
GWAS1633772_H
|
high grade ovarian serous adenocarcinoma QTL GWAS1633772 (human)
|
|
IAGP
|
rs7833298
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 8:128,068,411...128,068,412
|
|
|
Q
|
GWAS1018480_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018480 (human)
|
|
IAGP
|
rs11200014
| 8.0E-35 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr10:121,575,416...121,575,417
|
|
Q
|
GWAS1018481_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018481 (human)
|
|
IAGP
|
rs7931342
| 4.0E-14 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr11:69,227,030...69,227,031
|
|
Q
|
GWAS1018549_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018549 (human)
|
|
IAGP
|
rs73110464
| 2.0E-15 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:52,918,828...52,918,829
|
|
Q
|
GWAS1018551_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018551 (human)
|
|
IAGP
|
rs11571818
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr13:32,394,673...32,394,674
|
|
Q
|
GWAS1018552_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018552 (human)
|
|
IAGP
|
rs11844632
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr14:68,559,662...68,559,663
|
|
Q
|
GWAS1018620_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018620 (human)
|
|
IAGP
|
rs11907546
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr20:34,131,991...34,131,992
|
|
Q
|
GWAS1018623_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018623 (human)
|
|
IAGP
|
rs2300206
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr20:34,002,002...34,002,003
|
|
Q
|
GWAS1018625_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018625 (human)
|
|
IAGP
|
rs56084662
| 4.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr13:32,295,727...32,295,728
|
|
Q
|
GWAS1018680_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018680 (human)
|
|
IAGP
|
rs11119608
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:210,816,167...210,816,168
|
|
Q
|
GWAS1018681_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018681 (human)
|
|
IAGP
|
rs75316749
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 3:169,043,635...169,043,636
|
|
Q
|
GWAS1018745_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018745 (human)
|
|
IAGP
|
rs4604234
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 6:80,398,959...80,398,960
|
|
Q
|
GWAS1018828_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018828 (human)
|
|
IAGP
|
rs11907546
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr20:34,131,991...34,131,992
|
|
Q
|
GWAS1018829_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018829 (human)
|
|
IAGP
|
rs2300206
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr20:34,002,002...34,002,003
|
|
Q
|
GWAS1018928_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018928 (human)
|
|
IAGP
|
rs481519
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 3:27,285,723...27,285,724
|
|
Q
|
GWAS1018929_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018929 (human)
|
|
IAGP
|
rs7725218
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 5:1,282,299...1,282,300
|
|
Q
|
GWAS1117389_H
|
ovarian carcinoma QTL GWAS1117389 (human)
|
|
IAGP
|
rs7705526
| 8.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 5:1,285,859...1,285,860
|
|
Q
|
GWAS1117390_H
|
ovarian carcinoma QTL GWAS1117390 (human)
|
|
IAGP
|
rs7405776
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:37,733,029...37,733,030
|
|
Q
|
GWAS1117391_H
|
ovarian carcinoma QTL GWAS1117391 (human)
|
|
IAGP
|
rs11651755
| 8.0E-9 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:37,739,849...37,739,850
|
|
Q
|
GWAS1117392_H
|
ovarian carcinoma QTL GWAS1117392 (human)
|
|
IAGP
|
rs1879586
| 2.0E-19 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:45,489,971...45,489,972
|
|
Q
|
GWAS1117393_H
|
ovarian carcinoma QTL GWAS1117393 (human)
|
|
IAGP
|
rs7207826
| 2.0E-17 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:48,423,311...48,423,312
|
|
Q
|
GWAS1117394_H
|
ovarian carcinoma QTL GWAS1117394 (human)
|
|
IAGP
|
rs4808075
| 2.0E-19 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr19:17,279,482...17,279,483
|
|
Q
|
GWAS1117425_H
|
ovarian carcinoma QTL GWAS1117425 (human)
|
|
IAGP
|
rs10962692
| 9.0E-11 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 9:16,915,876...16,915,877
|
|
Q
|
GWAS1117427_H
|
ovarian carcinoma QTL GWAS1117427 (human)
|
|
IAGP
|
rs58722170
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 1:37,630,749...37,630,750
|
|
Q
|
GWAS1117429_H
|
ovarian carcinoma QTL GWAS1117429 (human)
|
|
IAGP
|
rs6005807
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr22:28,538,325...28,538,326
|
|
Q
|
GWAS1117431_H
|
ovarian carcinoma QTL GWAS1117431 (human)
|
|
IAGP
|
rs10069690
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 5:1,279,675...1,279,676
|
|
Q
|
GWAS1117432_H
|
ovarian carcinoma QTL GWAS1117432 (human)
|
|
IAGP
|
rs10962692
| 1.0E-14 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 9:16,915,876...16,915,877
|
|
Q
|
GWAS1117433_H
|
ovarian carcinoma QTL GWAS1117433 (human)
|
|
IAGP
|
rs1879586
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:45,489,971...45,489,972
|
|
Q
|
GWAS1117460_H
|
ovarian carcinoma QTL GWAS1117460 (human)
|
|
IAGP
|
rs17329882
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 4:119,028,805...119,028,806
|
|
Q
|
GWAS1117461_H
|
ovarian carcinoma QTL GWAS1117461 (human)
|
|
IAGP
|
rs10069690
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 5:1,279,675...1,279,676
|
|
Q
|
GWAS1117462_H
|
ovarian carcinoma QTL GWAS1117462 (human)
|
|
IAGP
|
rs7705526
| 7.0E-10 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 5:1,285,859...1,285,860
|
|
Q
|
GWAS1117463_H
|
ovarian carcinoma QTL GWAS1117463 (human)
|
|
IAGP
|
rs10962692
| 9.0E-36 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 9:16,915,876...16,915,877
|
|
Q
|
GWAS1117464_H
|
ovarian carcinoma QTL GWAS1117464 (human)
|
|
IAGP
|
rs8037137
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr15:90,963,407...90,963,408
|
|
Q
|
GWAS1117465_H
|
ovarian carcinoma QTL GWAS1117465 (human)
|
|
IAGP
|
rs143663961
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:30,854,202...30,854,203
|
|
Q
|
GWAS1117466_H
|
ovarian carcinoma QTL GWAS1117466 (human)
|
|
IAGP
|
rs1879586
| 2.0E-13 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:45,489,971...45,489,972
|
|
Q
|
GWAS1117467_H
|
ovarian carcinoma QTL GWAS1117467 (human)
|
|
IAGP
|
rs7207826
| 8.0E-13 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:48,423,311...48,423,312
|
|
Q
|
GWAS1117468_H
|
ovarian carcinoma QTL GWAS1117468 (human)
|
|
IAGP
|
rs4808075
| 2.0E-17 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr19:17,279,482...17,279,483
|
|
Q
|
GWAS1117470_H
|
ovarian carcinoma QTL GWAS1117470 (human)
|
|
IAGP
|
rs6456822
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 6:28,512,858...28,512,859
|
|
Q
|
GWAS1117471_H
|
ovarian carcinoma QTL GWAS1117471 (human)
|
|
IAGP
|
rs10962692
| 5.0E-64 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 9:16,915,876...16,915,877
|
|
Q
|
GWAS1117510_H
|
ovarian carcinoma QTL GWAS1117510 (human)
|
|
IAGP
|
rs8098244
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr18:23,825,589...23,825,590
|
|
Q
|
GWAS1118995_H
|
progression free survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1118995 (human)
|
|
IAGP
|
rs10500780
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr11:13,401,400...13,401,401
|
|
Q
|
GWAS1118996_H
|
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1118996 (human)
|
|
IAGP
|
rs1564271
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr10:26,722,183...26,722,184
|
|
Q
|
GWAS1118997_H
|
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1118997 (human)
|
|
IAGP
|
rs10899426
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr11:78,008,566...78,008,567
|
|
Q
|
GWAS1118998_H
|
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1118998 (human)
|
|
IAGP
|
rs4618572
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr 6:1,492,427...1,492,428
|
|
Q
|
GWAS1118999_H
|
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1118999 (human)
|
|
IAGP
|
rs295315
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr 3:141,643,383...141,643,384
|
|
Q
|
GWAS1119000_H
|
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119000 (human)
|
|
IAGP
|
rs17693104
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr10:80,608,465...80,608,466
|
|
Q
|
GWAS1119001_H
|
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119001 (human)
|
|
IAGP
|
rs868767
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr 3:141,658,488...141,658,489
|
|
Q
|
GWAS1119002_H
|
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119002 (human)
|
|
IAGP
|
rs2050203
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr20:24,451,198...24,451,199
|
|
Q
|
GWAS1119003_H
|
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119003 (human)
|
|
IAGP
|
rs17548007
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr12:102,981,636...102,981,637
|
|
Q
|
GWAS1119589_H
|
progression free survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119589 (human)
|
|
IAGP
|
rs10899426
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr11:78,008,566...78,008,567
|
|
Q
|
GWAS1119590_H
|
progression free survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119590 (human)
|
|
IAGP
|
rs6256
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr11:13,492,506...13,492,507
|
|
Q
|
GWAS1119591_H
|
progression free survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119591 (human)
|
|
IAGP
|
rs10832063
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr11:13,553,087...13,553,088
|
|
Q
|
GWAS1144562_H
|
ovarian carcinoma QTL GWAS1144562 (human)
|
|
IAGP
|
rs192503876
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr18:65,045,831...65,045,832
|
|
Q
|
GWAS1144563_H
|
ovarian carcinoma QTL GWAS1144563 (human)
|
|
IAGP
|
rs80314337
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr18:65,221,472...65,221,473
|
|
Q
|
GWAS1144564_H
|
ovarian carcinoma QTL GWAS1144564 (human)
|
|
IAGP
|
rs11873753
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr18:75,985,500...75,985,501
|
|
Q
|
GWAS1144565_H
|
ovarian carcinoma QTL GWAS1144565 (human)
|
|
IAGP
|
rs137657
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr22:39,337,237...39,337,238
|
|
Q
|
GWAS1144566_H
|
ovarian carcinoma QTL GWAS1144566 (human)
|
|
IAGP
|
rs7671115
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 4:164,203,350...164,203,351
|
|
Q
|
GWAS1144567_H
|
ovarian carcinoma QTL GWAS1144567 (human)
|
|
IAGP
|
rs1366161
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 5:5,174,755...5,174,756
|
|
Q
|
GWAS1144612_H
|
ovarian carcinoma QTL GWAS1144612 (human)
|
|
IAGP
|
rs151055883
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 5:143,894,315...143,894,316
|
|
Q
|
GWAS1144613_H
|
ovarian carcinoma QTL GWAS1144613 (human)
|
|
IAGP
|
rs77663385
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 6:44,327,218...44,327,219
|
|
Q
|
GWAS1144614_H
|
ovarian carcinoma QTL GWAS1144614 (human)
|
|
IAGP
|
rs7740903
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 6:146,677,054...146,677,055
|
|
Q
|
GWAS1144615_H
|
ovarian carcinoma QTL GWAS1144615 (human)
|
|
IAGP
|
rs76926936
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 7:89,698,682...89,698,683
|
|
Q
|
GWAS1144616_H
|
ovarian carcinoma QTL GWAS1144616 (human)
|
|
IAGP
|
rs73494486
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 9:98,579,569...98,579,570
|
|
Q
|
GWAS1144617_H
|
ovarian carcinoma QTL GWAS1144617 (human)
|
|
IAGP
|
rs77336990
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr10:48,270,719...48,270,720
|
|
Q
|
GWAS1144618_H
|
ovarian carcinoma QTL GWAS1144618 (human)
|
|
IAGP
|
rs9989364
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr16:63,960,276...63,960,277
|
|
Q
|
GWAS1144619_H
|
ovarian carcinoma QTL GWAS1144619 (human)
|
|
IAGP
|
rs141803457
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr16:68,366,522...68,366,523
|
|
Q
|
GWAS1144620_H
|
ovarian carcinoma QTL GWAS1144620 (human)
|
|
IAGP
|
rs137866923
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr16:68,497,433...68,497,434
|
|
Q
|
GWAS1144621_H
|
ovarian carcinoma QTL GWAS1144621 (human)
|
|
IAGP
|
rs139505845
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr17:57,289,728...57,289,729
|
|
Q
|
GWAS1144658_H
|
ovarian carcinoma QTL GWAS1144658 (human)
|
|
IAGP
|
rs138807553
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr18:33,625,004...33,625,005
|
|
Q
|
GWAS1144659_H
|
ovarian carcinoma QTL GWAS1144659 (human)
|
|
IAGP
|
rs78286182
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr18:75,988,278...75,988,279
|
|
Q
|
GWAS1146472_H
|
ovarian carcinoma QTL GWAS1146472 (human)
|
|
IAGP
|
rs484686
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 1:172,183,062...172,183,063
|
|
Q
|
GWAS1146473_H
|
ovarian carcinoma QTL GWAS1146473 (human)
|
|
IAGP
|
rs537364753
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 2:184,453,308...184,453,309
|
|
Q
|
GWAS1146474_H
|
ovarian carcinoma QTL GWAS1146474 (human)
|
|
IAGP
|
rs75693602
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 2:205,631,096...205,631,097
|
|
Q
|
GWAS1146475_H
|
ovarian carcinoma QTL GWAS1146475 (human)
|
|
IAGP
|
rs150007914
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 3:171,410,134...171,410,135
|
|
Q
|
GWAS1146476_H
|
ovarian carcinoma QTL GWAS1146476 (human)
|
|
IAGP
|
rs7671115
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 4:164,203,350...164,203,351
|
|
Q
|
GWAS1146477_H
|
ovarian carcinoma QTL GWAS1146477 (human)
|
|
IAGP
|
rs57490377
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 4:185,621,753...185,621,754
|
|
Q
|
GWAS1146478_H
|
ovarian carcinoma QTL GWAS1146478 (human)
|
|
IAGP
|
rs1366161
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 5:5,174,755...5,174,756
|
|
Q
|
GWAS1146479_H
|
ovarian carcinoma QTL GWAS1146479 (human)
|
|
IAGP
|
rs151055883
| 6.0E-7 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 5:143,894,315...143,894,316
|
|
Q
|
GWAS1146480_H
|
ovarian carcinoma QTL GWAS1146480 (human)
|
|
IAGP
|
rs77663385
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 6:44,327,218...44,327,219
|
|
Q
|
GWAS1146481_H
|
ovarian carcinoma QTL GWAS1146481 (human)
|
|
IAGP
|
rs7740903
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 6:146,677,054...146,677,055
|
|
Q
|
GWAS1146482_H
|
ovarian carcinoma QTL GWAS1146482 (human)
|
|
IAGP
|
rs76926936
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 7:89,698,682...89,698,683
|
|
Q
|
GWAS1146483_H
|
ovarian carcinoma QTL GWAS1146483 (human)
|
|
IAGP
|
rs147476757
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 9:126,011,262...126,011,263
|
|
Q
|
GWAS1146515_H
|
ovarian carcinoma QTL GWAS1146515 (human)
|
|
IAGP
|
rs201368489
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr14:64,414,689...64,414,690
|
|
Q
|
GWAS1146516_H
|
ovarian carcinoma QTL GWAS1146516 (human)
|
|
IAGP
|
rs141803457
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr16:68,366,522...68,366,523
|
|
Q
|
GWAS1146517_H
|
ovarian carcinoma QTL GWAS1146517 (human)
|
|
IAGP
|
rs137866923
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr16:68,497,433...68,497,434
|
|
Q
|
GWAS1146518_H
|
ovarian carcinoma QTL GWAS1146518 (human)
|
|
IAGP
|
rs572011593
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr17:27,694,464...27,694,465
|
|
Q
|
GWAS1146519_H
|
ovarian carcinoma QTL GWAS1146519 (human)
|
|
IAGP
|
rs139505845
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr17:57,289,728...57,289,729
|
|
Q
|
GWAS1146520_H
|
ovarian carcinoma QTL GWAS1146520 (human)
|
|
IAGP
|
rs146540010
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr17:69,216,249...69,216,250
|
|
Q
|
GWAS1161219_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161219 (human)
|
|
IAGP
|
rs77548871
| 5.0E-9 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr 1:155,016,057...155,016,058
|
|
Q
|
GWAS1161220_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161220 (human)
|
|
IAGP
|
rs17041869
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr 2:111,138,666...111,138,667
|
|
Q
|
GWAS1161221_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161221 (human)
|
|
IAGP
|
rs739704
| 3.0E-14 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr 7:27,950,149...27,950,150
|
|
Q
|
GWAS1161222_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161222 (human)
|
|
IAGP
|
rs720475
| 7.0E-12 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr 7:144,377,836...144,377,837
|
|
Q
|
GWAS1161242_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161242 (human)
|
|
IAGP
|
rs7937840
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr11:62,126,500...62,126,501
|
|
Q
|
GWAS1161243_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161243 (human)
|
|
IAGP
|
rs72932523
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr11:69,138,652...69,138,653
|
|
Q
|
GWAS1161244_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161244 (human)
|
|
IAGP
|
rs2277509
| 9.0E-12 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr14:91,283,251...91,283,252
|
|
Q
|
GWAS1161245_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161245 (human)
|
|
IAGP
|
rs2628317
| 4.0E-16 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr17:55,135,212...55,135,213
|
|
Q
|
GWAS1161261_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161261 (human)
|
|
IAGP
|
rs1469713
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr19:19,417,997...19,417,998
|
|
Q
|
GWAS1164825_H
|
lung carcinoma QTL GWAS1164825 (human)
|
|
IAGP
|
rs56404467
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr13:32,265,853...32,265,854
|
|
Q
|
GWAS1201787_H
|
ovarian carcinoma QTL GWAS1201787 (human)
|
|
IAGP
|
rs12061931
| 6.0E-8 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr 1:3,779,792...3,779,793
|
|
Q
|
GWAS1208474_H
|
ovarian carcinoma QTL GWAS1208474 (human)
|
|
IAGP
|
rs185345278
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 1:93,933,038...93,933,039
|
|
Q
|
GWAS1208475_H
|
ovarian carcinoma QTL GWAS1208475 (human)
|
|
IAGP
|
rs188625872
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 1:156,114,696...156,114,697
|
|
Q
|
GWAS1208476_H
|
ovarian carcinoma QTL GWAS1208476 (human)
|
|
IAGP
|
rs12117623
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 1:172,072,640...172,072,641
|
|
Q
|
GWAS1208477_H
|
ovarian carcinoma QTL GWAS1208477 (human)
|
|
IAGP
|
rs17027263
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 2:86,459,965...86,459,966
|
|
Q
|
GWAS1208478_H
|
ovarian carcinoma QTL GWAS1208478 (human)
|
|
IAGP
|
rs12658731
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 5:5,169,477...5,169,478
|
|
Q
|
GWAS1208479_H
|
ovarian carcinoma QTL GWAS1208479 (human)
|
|
IAGP
|
rs60982503
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 5:180,485,036...180,485,037
|
|
Q
|
GWAS1208648_H
|
ovarian carcinoma QTL GWAS1208648 (human)
|
|
IAGP
|
rs303051
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 6:10,403,963...10,403,964
|
|
Q
|
GWAS1208649_H
|
ovarian carcinoma QTL GWAS1208649 (human)
|
|
IAGP
|
rs56855829
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 6:35,464,877...35,464,878
|
|
Q
|
GWAS1208650_H
|
ovarian carcinoma QTL GWAS1208650 (human)
|
|
IAGP
|
rs73589840
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 6:146,688,554...146,688,555
|
|
Q
|
GWAS1208651_H
|
ovarian carcinoma QTL GWAS1208651 (human)
|
|
IAGP
|
rs10117922
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 9:87,680,655...87,680,656
|
|
Q
|
GWAS1208652_H
|
ovarian carcinoma QTL GWAS1208652 (human)
|
|
IAGP
|
rs2615880
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr10:115,937,294...115,937,295
|
|
Q
|
GWAS1208653_H
|
ovarian carcinoma QTL GWAS1208653 (human)
|
|
IAGP
|
rs58355101
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr12:70,257,391...70,257,392
|
|
Q
|
GWAS1208654_H
|
ovarian carcinoma QTL GWAS1208654 (human)
|
|
IAGP
|
rs1495352
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr12:70,359,064...70,359,065
|
|
Q
|
GWAS1208655_H
|
ovarian carcinoma QTL GWAS1208655 (human)
|
|
IAGP
|
rs75921351
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr16:54,596,587...54,596,588
|
|
Q
|
GWAS1208656_H
|
ovarian carcinoma QTL GWAS1208656 (human)
|
|
IAGP
|
rs145065165
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr16:55,347,327...55,347,328
|
|
Q
|
GWAS1208657_H
|
ovarian carcinoma QTL GWAS1208657 (human)
|
|
IAGP
|
rs11870446
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr17:5,857,509...5,857,510
|
|
Q
|
GWAS1209033_H
|
ovarian carcinoma QTL GWAS1209033 (human)
|
|
IAGP
|
rs12151036
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr19:58,202,868...58,202,869
|
|
Q
|
GWAS1209034_H
|
ovarian carcinoma QTL GWAS1209034 (human)
|
|
IAGP
|
rs1884920
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr20:56,648,010...56,648,011
|
|
Q
|
GWAS1209035_H
|
ovarian carcinoma QTL GWAS1209035 (human)
|
|
IAGP
|
rs137672
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr22:39,341,089...39,341,090
|
|
Q
|
GWAS1233327_H
|
neuroimaging measurement QTL GWAS1233327 (human)
|
|
IAGP
|
rs550057
| 2.0E-14 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr 9:133,271,182...133,271,183
|
|
Q
|
GWAS1314983_H
|
ovarian carcinoma QTL GWAS1314983 (human)
|
|
IAGP
|
rs115128033
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr 7:57,372,353...57,372,354
|
|
Q
|
GWAS1314984_H
|
ovarian carcinoma QTL GWAS1314984 (human)
|
|
IAGP
|
rs150698072
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr 7:122,011,697...122,011,698
|
|
Q
|
GWAS1314985_H
|
ovarian carcinoma QTL GWAS1314985 (human)
|
|
IAGP
|
rs4726091
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr 7:151,775,905...151,775,906
|
|
Q
|
GWAS1314986_H
|
ovarian carcinoma QTL GWAS1314986 (human)
|
|
IAGP
|
rs182634476
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr 8:144,437,000...144,437,001
|
|
Q
|
GWAS1314987_H
|
ovarian carcinoma QTL GWAS1314987 (human)
|
|
IAGP
|
rs181962423
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr 9:34,972,355...34,972,356
|
|
Q
|
GWAS1314988_H
|
ovarian carcinoma QTL GWAS1314988 (human)
|
|
IAGP
|
rs141131642
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr11:10,778,732...10,778,733
|
|
Q
|
GWAS1314989_H
|
ovarian carcinoma QTL GWAS1314989 (human)
|
|
IAGP
|
rs67812265
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr11:57,776,189...57,776,190
|
|
Q
|
GWAS1315182_H
|
ovarian carcinoma QTL GWAS1315182 (human)
|
|
IAGP
|
rs201166499
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr17:41,734,613...41,734,614
|
|
Q
|
GWAS1321449_H
|
ovarian carcinoma QTL GWAS1321449 (human)
|
|
IAGP
|
rs113446565
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr X:3,776,745...3,776,746
|
|
Q
|
GWAS1321633_H
|
ovarian carcinoma QTL GWAS1321633 (human)
|
|
IAGP
|
rs1164587
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr13:96,391,464...96,391,465
|
|
Q
|
GWAS1321634_H
|
ovarian carcinoma QTL GWAS1321634 (human)
|
|
IAGP
|
rs11659469
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr18:49,657,424...49,657,425
|
|
Q
|
GWAS1321635_H
|
ovarian carcinoma QTL GWAS1321635 (human)
|
|
IAGP
|
rs11684751
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 2:150,393,944...150,393,945
|
|
Q
|
GWAS1321636_H
|
ovarian carcinoma QTL GWAS1321636 (human)
|
|
IAGP
|
rs11724690
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 4:185,843,593...185,843,594
|
|
Q
|
GWAS1321637_H
|
ovarian carcinoma QTL GWAS1321637 (human)
|
|
IAGP
|
rs11973028
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 7:27,853,217...27,853,218
|
|
Q
|
GWAS1321638_H
|
ovarian carcinoma QTL GWAS1321638 (human)
|
|
IAGP
|
rs11980115
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 7:133,141,119...133,141,120
|
|
Q
|
GWAS1321639_H
|
ovarian carcinoma QTL GWAS1321639 (human)
|
|
IAGP
|
rs12603880
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr17:57,668,632...57,668,633
|
|
Q
|
GWAS1321640_H
|
ovarian carcinoma QTL GWAS1321640 (human)
|
|
IAGP
|
rs135573
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr22:46,131,359...46,131,360
|
|
Q
|
GWAS1321641_H
|
ovarian carcinoma QTL GWAS1321641 (human)
|
|
IAGP
|
rs1413017
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr20:12,691,366...12,691,367
|
|
Q
|
GWAS1321642_H
|
ovarian carcinoma QTL GWAS1321642 (human)
|
|
IAGP
|
rs144199732
| 7.0E-7 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr X:43,022,624...43,022,625
|
|
Q
|
GWAS1321643_H
|
ovarian carcinoma QTL GWAS1321643 (human)
|
|
IAGP
|
rs146343288
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 6:17,689,625...17,689,626
|
|
Q
|
GWAS1321644_H
|
ovarian carcinoma QTL GWAS1321644 (human)
|
|
IAGP
|
rs146917711
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 3:112,609,781...112,609,782
|
|
Q
|
GWAS1321645_H
|
ovarian carcinoma QTL GWAS1321645 (human)
|
|
IAGP
|
rs11426758
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr17:4,274,199...4,274,200
|
|
Q
|
GWAS1321827_H
|
ovarian carcinoma QTL GWAS1321827 (human)
|
|
IAGP
|
rs12568748
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 1:221,657,667...221,657,668
|
|
Q
|
GWAS1321828_H
|
ovarian carcinoma QTL GWAS1321828 (human)
|
|
IAGP
|
rs12623068
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 2:7,182,908...7,182,909
|
|
Q
|
GWAS1321829_H
|
ovarian carcinoma QTL GWAS1321829 (human)
|
|
IAGP
|
rs10009522
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 4:153,242,242...153,242,243
|
|
Q
|
GWAS1321830_H
|
ovarian carcinoma QTL GWAS1321830 (human)
|
|
IAGP
|
rs10260419
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 7:11,524,758...11,524,759
|
|
Q
|
GWAS1321831_H
|
ovarian carcinoma QTL GWAS1321831 (human)
|
|
IAGP
|
rs10400919
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr15:27,084,081...27,084,082
|
|
Q
|
GWAS1321832_H
|
ovarian carcinoma QTL GWAS1321832 (human)
|
|
IAGP
|
rs10627733
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 1:21,141,377...21,141,378
|
|
Q
|
GWAS1321833_H
|
ovarian carcinoma QTL GWAS1321833 (human)
|
|
IAGP
|
rs111478044
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr21:21,308,068...21,308,069
|
|
Q
|
GWAS1321834_H
|
ovarian carcinoma QTL GWAS1321834 (human)
|
|
IAGP
|
rs11150225
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr16:79,856,062...79,856,063
|
|
Q
|
GWAS1321835_H
|
ovarian carcinoma QTL GWAS1321835 (human)
|
|
IAGP
|
rs111970895
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 5:102,301,953...102,301,957
|
|
Q
|
GWAS1325893_H
|
ovarian carcinoma QTL GWAS1325893 (human)
|
|
IAGP
|
rs72745575
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 9:81,548,365...81,548,366
|
|
Q
|
GWAS1326123_H
|
ovarian carcinoma QTL GWAS1326123 (human)
|
|
IAGP
|
rs7644028
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 3:176,972,255...176,972,256
|
|
Q
|
GWAS1326124_H
|
ovarian carcinoma QTL GWAS1326124 (human)
|
|
IAGP
|
rs78649302
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr13:113,481,059...113,481,060
|
|
Q
|
GWAS1326125_H
|
ovarian carcinoma QTL GWAS1326125 (human)
|
|
IAGP
|
rs78950910
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr13:29,266,071...29,266,072
|
|
Q
|
GWAS1326126_H
|
ovarian carcinoma QTL GWAS1326126 (human)
|
|
IAGP
|
rs79925169
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 9:89,469,330...89,469,331
|
|
Q
|
GWAS1326127_H
|
ovarian carcinoma QTL GWAS1326127 (human)
|
|
IAGP
|
rs80119973
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 8:13,963,095...13,963,096
|
|
Q
|
GWAS1326128_H
|
ovarian carcinoma QTL GWAS1326128 (human)
|
|
IAGP
|
rs8069681
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr17:5,064,847...5,064,848
|
|
Q
|
GWAS1326129_H
|
ovarian carcinoma QTL GWAS1326129 (human)
|
|
IAGP
|
rs870274
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr10:122,120,548...122,120,549
|
|
Q
|
GWAS1326130_H
|
ovarian carcinoma QTL GWAS1326130 (human)
|
|
IAGP
|
rs9316411
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr13:48,747,718...48,747,719
|
|
Q
|
GWAS1326131_H
|
ovarian carcinoma QTL GWAS1326131 (human)
|
|
IAGP
|
rs9791676
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 7:42,053,156...42,053,157
|
|
Q
|
GWAS1326132_H
|
ovarian carcinoma QTL GWAS1326132 (human)
|
|
IAGP
|
rs151224156
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 7:57,784,687...57,784,688
|
|
Q
|
GWAS1326133_H
|
ovarian carcinoma QTL GWAS1326133 (human)
|
|
IAGP
|
rs1728807
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 3:11,007,643...11,007,644
|
|
Q
|
GWAS1326134_H
|
ovarian carcinoma QTL GWAS1326134 (human)
|
|
IAGP
|
rs17808848
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 5:175,210,799...175,210,800
|
|
Q
|
GWAS1326135_H
|
ovarian carcinoma QTL GWAS1326135 (human)
|
|
IAGP
|
rs1791890
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr11:116,120,763...116,120,764
|
|
Q
|
GWAS1326365_H
|
ovarian carcinoma QTL GWAS1326365 (human)
|
|
IAGP
|
rs1800351
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr13:23,250,644...23,250,645
|
|
Q
|
GWAS1326366_H
|
ovarian carcinoma QTL GWAS1326366 (human)
|
|
IAGP
|
rs185335029
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 3:26,787,883...26,787,884
|
|
Q
|
GWAS1326367_H
|
ovarian carcinoma QTL GWAS1326367 (human)
|
|
IAGP
|
rs2371271
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 2:211,451,963...211,451,964
|
|
Q
|
GWAS1326368_H
|
ovarian carcinoma QTL GWAS1326368 (human)
|
|
IAGP
|
rs243172
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr14:89,546,219...89,546,220
|
|
Q
|
GWAS1326369_H
|
ovarian carcinoma QTL GWAS1326369 (human)
|
|
IAGP
|
rs2829235
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr21:24,659,554...24,659,555
|
|
Q
|
GWAS1326370_H
|
ovarian carcinoma QTL GWAS1326370 (human)
|
|
IAGP
|
rs28734075
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 4:3,824,215...3,824,216
|
|
Q
|
GWAS1326371_H
|
ovarian carcinoma QTL GWAS1326371 (human)
|
|
IAGP
|
rs34097398
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr X:33,452,414...33,452,415
|
|
Q
|
GWAS1326372_H
|
ovarian carcinoma QTL GWAS1326372 (human)
|
|
IAGP
|
rs34350340
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr X:119,837,615...119,837,616
|
|
Q
|
GWAS1326373_H
|
ovarian carcinoma QTL GWAS1326373 (human)
|
|
IAGP
|
rs34357515
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr19:3,197,621...3,197,622
|
|
Q
|
GWAS1326374_H
|
ovarian carcinoma QTL GWAS1326374 (human)
|
|
IAGP
|
rs35941888
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr22:28,343,529...28,343,530
|
|
Q
|
GWAS1326623_H
|
ovarian carcinoma QTL GWAS1326623 (human)
|
|
IAGP
|
rs40409
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 3:61,992,237...61,992,238
|
|
Q
|
GWAS1326862_H
|
ovarian carcinoma QTL GWAS1326862 (human)
|
|
IAGP
|
rs56236040
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 7:51,423,896...51,423,897
|
|
Q
|
GWAS1326863_H
|
ovarian carcinoma QTL GWAS1326863 (human)
|
|
IAGP
|
rs57960590
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 6:151,590,844...151,590,845
|
|
Q
|
GWAS1326864_H
|
ovarian carcinoma QTL GWAS1326864 (human)
|
|
IAGP
|
rs58142303
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 5:90,981,864...90,981,865
|
|
Q
|
GWAS1326865_H
|
ovarian carcinoma QTL GWAS1326865 (human)
|
|
IAGP
|
rs59923016
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr16:49,765,544...49,765,545
|
|
Q
|
GWAS1326866_H
|
ovarian carcinoma QTL GWAS1326866 (human)
|
|
IAGP
|
rs60930737
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr10:25,607,085...25,607,092
|
|
Q
|
GWAS1326867_H
|
ovarian carcinoma QTL GWAS1326867 (human)
|
|
IAGP
|
rs4362851
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 4:167,363,437...167,363,438
|
|
Q
|
GWAS1326868_H
|
ovarian carcinoma QTL GWAS1326868 (human)
|
|
IAGP
|
rs4709698
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 6:163,301,732...163,301,733
|
|
Q
|
GWAS1326869_H
|
ovarian carcinoma QTL GWAS1326869 (human)
|
|
IAGP
|
rs4918665
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr10:111,552,672...111,552,673
|
|
Q
|
GWAS1326870_H
|
ovarian carcinoma QTL GWAS1326870 (human)
|
|
IAGP
|
rs6461701
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 7:2,916,633...2,916,634
|
|
Q
|
GWAS1326871_H
|
ovarian carcinoma QTL GWAS1326871 (human)
|
|
IAGP
|
rs67729017
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 8:50,701,586...50,701,587
|
|
Q
|
GWAS1326872_H
|
ovarian carcinoma QTL GWAS1326872 (human)
|
|
IAGP
|
rs70959845
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 2:60,572,848...60,572,849
|
|
Q
|
GWAS1326873_H
|
ovarian carcinoma QTL GWAS1326873 (human)
|
|
IAGP
|
rs7172033
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr15:59,949,310...59,949,311
|
|
Q
|
GWAS1326874_H
|
ovarian carcinoma QTL GWAS1326874 (human)
|
|
IAGP
|
rs72492309
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 6:32,541,977...32,541,978
|
|
Q
|
GWAS1327355_H
|
ovarian carcinoma QTL GWAS1327355 (human)
|
|
IAGP
|
rs987254
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 3:169,266,197...169,266,198
|
|
Q
|
GWAS1339947_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1339947 (human)
|
|
IAGP
|
rs12243396
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr10:86,171,880...86,171,881
|
|
Q
|
GWAS1339948_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1339948 (human)
|
|
IAGP
|
rs35709804
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr10:133,024,074...133,024,075
|
|
Q
|
GWAS1339949_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1339949 (human)
|
|
IAGP
|
rs5752640
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr22:27,807,762...27,807,763
|
|
Q
|
GWAS1339950_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1339950 (human)
|
|
IAGP
|
rs735252
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr22:47,124,913...47,124,914
|
|
Q
|
GWAS1339951_H
|
progression free survival, ovarian carcinoma QTL GWAS1339951 (human)
|
|
IAGP
|
rs67654717
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 2:15,170,390...15,170,391
|
|
Q
|
GWAS1339985_H
|
progression free survival, ovarian carcinoma QTL GWAS1339985 (human)
|
|
IAGP
|
rs35241450
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr22:29,117,567...29,117,568
|
|
Q
|
GWAS1340144_H
|
progression free survival, ovarian carcinoma QTL GWAS1340144 (human)
|
|
IAGP
|
rs2125653
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 4:18,116,414...18,116,415
|
|
Q
|
GWAS1340145_H
|
progression free survival, ovarian carcinoma QTL GWAS1340145 (human)
|
|
IAGP
|
rs74760478
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 6:10,841,524...10,841,525
|
|
Q
|
GWAS1340146_H
|
progression free survival, ovarian carcinoma QTL GWAS1340146 (human)
|
|
IAGP
|
rs139827288
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 7:37,228,787...37,228,788
|
|
Q
|
GWAS1340147_H
|
progression free survival, ovarian carcinoma QTL GWAS1340147 (human)
|
|
IAGP
|
rs2017441
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 9:84,923,681...84,923,682
|
|
Q
|
GWAS1340148_H
|
progression free survival, ovarian carcinoma QTL GWAS1340148 (human)
|
|
IAGP
|
rs78007224
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr14:36,881,274...36,881,275
|
|
Q
|
GWAS1340149_H
|
progression free survival, ovarian carcinoma QTL GWAS1340149 (human)
|
|
IAGP
|
rs58244431
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr14:58,210,731...58,210,732
|
|
Q
|
GWAS1340150_H
|
progression free survival, ovarian carcinoma QTL GWAS1340150 (human)
|
|
IAGP
|
rs2847516
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr18:36,339,642...36,339,643
|
|
Q
|
GWAS1340151_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340151 (human)
|
|
IAGP
|
rs55950243
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 1:29,843,121...29,843,122
|
|
Q
|
GWAS1340152_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340152 (human)
|
|
IAGP
|
rs147138325
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 1:65,863,804...65,863,805
|
|
Q
|
GWAS1340153_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340153 (human)
|
|
IAGP
|
rs58116956
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 1:81,655,410...81,655,411
|
|
Q
|
GWAS1340318_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340318 (human)
|
|
IAGP
|
rs2070707
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 2:79,121,070...79,121,071
|
|
Q
|
GWAS1340319_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340319 (human)
|
|
IAGP
|
rs17018999
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 2:80,340,409...80,340,410
|
|
Q
|
GWAS1340320_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340320 (human)
|
|
IAGP
|
rs115676291
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 2:124,177,399...124,177,400
|
|
Q
|
GWAS1340321_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340321 (human)
|
|
IAGP
|
rs66530326
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 2:124,314,987...124,314,988
|
|
Q
|
GWAS1340322_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340322 (human)
|
|
IAGP
|
rs1082422
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 3:76,808,163...76,808,164
|
|
Q
|
GWAS1340323_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340323 (human)
|
|
IAGP
|
rs113526453
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 3:97,419,623...97,419,624
|
|
Q
|
GWAS1340324_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340324 (human)
|
|
IAGP
|
rs11096798
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 4:36,092,509...36,092,510
|
|
Q
|
GWAS1340325_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340325 (human)
|
|
IAGP
|
rs142157655
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 4:113,992,588...113,992,589
|
|
Q
|
GWAS1340326_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340326 (human)
|
|
IAGP
|
rs59152766
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 5:59,531,580...59,531,581
|
|
Q
|
GWAS1340327_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340327 (human)
|
|
IAGP
|
rs35893266
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 5:76,450,735...76,450,736
|
|
Q
|
GWAS1340328_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340328 (human)
|
|
IAGP
|
rs144087161
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 7:114,572,597...114,572,598
|
|
Q
|
GWAS1340329_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340329 (human)
|
|
IAGP
|
rs139156430
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 7:155,319,558...155,319,559
|
|
Q
|
GWAS1340330_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340330 (human)
|
|
IAGP
|
rs6985728
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 8:19,794,927...19,794,928
|
|
Q
|
GWAS1340493_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340493 (human)
|
|
IAGP
|
rs72718849
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 8:121,577,705...121,577,706
|
|
Q
|
GWAS1340494_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340494 (human)
|
|
IAGP
|
rs11141915
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 9:87,620,879...87,620,880
|
|
Q
|
GWAS1340495_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340495 (human)
|
|
IAGP
|
rs10752194
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr10:6,072,330...6,072,331
|
|
Q
|
GWAS1343674_H
|
ovarian carcinoma QTL GWAS1343674 (human)
|
|
IAGP
|
rs146976708
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr 1:48,298,840...48,298,841
|
|
Q
|
GWAS1343675_H
|
ovarian carcinoma QTL GWAS1343675 (human)
|
|
IAGP
|
rs115092288
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr 1:114,673,738...114,673,739
|
|
Q
|
GWAS1343676_H
|
ovarian carcinoma QTL GWAS1343676 (human)
|
|
IAGP
|
rs80104686
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr 3:45,158,636...45,158,637
|
|
Q
|
GWAS1343677_H
|
ovarian carcinoma QTL GWAS1343677 (human)
|
|
IAGP
|
rs80192073
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr 4:40,121,779...40,121,780
|
|
Q
|
GWAS1343678_H
|
ovarian carcinoma QTL GWAS1343678 (human)
|
|
IAGP
|
rs74375290
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr 6:31,129,248...31,129,249
|
|
Q
|
GWAS1343679_H
|
ovarian carcinoma QTL GWAS1343679 (human)
|
|
IAGP
|
rs137852915
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr 6:145,686,276...145,686,277
|
|
Q
|
GWAS1353931_H
|
family history of lung cancer QTL GWAS1353931 (human)
|
|
IAGP
|
rs11571833
| 8.0E-12 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr13:32,398,489...32,398,490
|
|
Q
|
GWAS1376382_H
|
overall survival, ovarian carcinoma QTL GWAS1376382 (human)
|
|
IAGP
|
rs7631664
| 9.0E-10 |
|
|
GWAS_CATALOG |
PMID:34930913 |
|
NCBI chr 3:4,709,568...4,709,569
|
|
Q
|
GWAS1401509_H
|
breast cancer, ovarian carcinoma QTL GWAS1401509 (human)
|
|
IAGP
|
rs3814113
| 2.0E-43 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 9:16,915,023...16,915,024
|
|
Q
|
GWAS1402492_H
|
breast cancer, ovarian carcinoma QTL GWAS1402492 (human)
|
|
IAGP
|
rs1219648
| 4E-254 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr10:121,586,676...121,586,677
|
|
Q
|
GWAS1402493_H
|
breast cancer, ovarian carcinoma QTL GWAS1402493 (human)
|
|
IAGP
|
rs7098100
| 4.0E-27 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr10:21,545,607...21,545,608
|
|
Q
|
GWAS1402494_H
|
breast cancer, ovarian carcinoma QTL GWAS1402494 (human)
|
|
IAGP
|
rs2277509
| 2.0E-11 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr14:91,283,251...91,283,252
|
|
Q
|
GWAS1402495_H
|
breast cancer, ovarian carcinoma QTL GWAS1402495 (human)
|
|
IAGP
|
rs10498635
| 9.0E-13 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr14:92,636,964...92,636,965
|
|
Q
|
GWAS1402496_H
|
breast cancer, ovarian carcinoma QTL GWAS1402496 (human)
|
|
IAGP
|
rs244353
| 1.0E-31 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr17:55,117,408...55,117,409
|
|
Q
|
GWAS1402497_H
|
breast cancer, ovarian carcinoma QTL GWAS1402497 (human)
|
|
IAGP
|
rs4808616
| 2.0E-23 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr19:17,292,224...17,292,225
|
|
Q
|
GWAS1402498_H
|
breast cancer, ovarian carcinoma QTL GWAS1402498 (human)
|
|
IAGP
|
rs2916074
| 2.0E-11 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr19:19,419,461...19,419,462
|
|
Q
|
GWAS1402499_H
|
breast cancer, ovarian carcinoma QTL GWAS1402499 (human)
|
|
IAGP
|
rs3769823
| 1.0E-16 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 2:201,258,272...201,258,273
|
|
Q
|
GWAS1402500_H
|
breast cancer, ovarian carcinoma QTL GWAS1402500 (human)
|
|
IAGP
|
rs1474961
| 2.0E-15 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr22:28,643,439...28,643,440
|
|
Q
|
GWAS1402501_H
|
breast cancer, ovarian carcinoma QTL GWAS1402501 (human)
|
|
IAGP
|
rs9878602
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 3:71,486,187...71,486,188
|
|
Q
|
GWAS1402502_H
|
breast cancer, ovarian carcinoma QTL GWAS1402502 (human)
|
|
IAGP
|
rs6826366
| 3.0E-28 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 4:174,924,959...174,924,960
|
|
Q
|
GWAS1402503_H
|
breast cancer, ovarian carcinoma QTL GWAS1402503 (human)
|
|
IAGP
|
rs10069690
| 5.0E-23 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 5:1,279,675...1,279,676
|
|
Q
|
GWAS1402504_H
|
breast cancer, ovarian carcinoma QTL GWAS1402504 (human)
|
|
IAGP
|
rs381551
| 2.0E-12 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 6:13,716,491...13,716,492
|
|
Q
|
GWAS1402505_H
|
breast cancer, ovarian carcinoma QTL GWAS1402505 (human)
|
|
IAGP
|
rs851980
| 9.0E-20 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 6:151,706,820...151,706,821
|
|
Q
|
GWAS1402506_H
|
breast cancer, ovarian carcinoma QTL GWAS1402506 (human)
|
|
IAGP
|
rs720475
| 9.0E-11 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 7:144,377,836...144,377,837
|
|
Q
|
GWAS1402507_H
|
breast cancer, ovarian carcinoma QTL GWAS1402507 (human)
|
|
IAGP
|
rs7017073
| 4.0E-14 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 8:128,192,016...128,192,017
|
|
Q
|
GWAS1402732_H
|
breast cancer, ovarian carcinoma QTL GWAS1402732 (human)
|
|
IAGP
|
rs2941478
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 8:75,564,502...75,564,503
|
|
Q
|
GWAS1402733_H
|
breast cancer, ovarian carcinoma QTL GWAS1402733 (human)
|
|
IAGP
|
rs630965
| 1.0E-63 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 9:108,123,199...108,123,200
|
|
Q
|
GWAS1404232_H
|
breast cancer, ovarian carcinoma QTL GWAS1404232 (human)
|
|
IAGP
|
rs495828
| 7.0E-11 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 9:133,279,294...133,279,295
|
|
Q
|
GWAS1424873_H
|
ovarian carcinoma, COVID-19 QTL GWAS1424873 (human)
|
|
IAGP
|
rs145526382
| 7.0E-9 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr 9:133,246,236...133,246,237
|
|
Q
|
GWAS1424874_H
|
ovarian carcinoma, COVID-19 QTL GWAS1424874 (human)
|
|
IAGP
|
rs554833
| 1E-88 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr 9:133,271,745...133,271,746
|
|
Q
|
GWAS1424875_H
|
ovarian carcinoma, COVID-19 QTL GWAS1424875 (human)
|
|
IAGP
|
rs56343119
| 1.0E-22 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr 9:133,370,796...133,370,797
|
|
Q
|
GWAS1424876_H
|
ovarian carcinoma, COVID-19 QTL GWAS1424876 (human)
|
|
IAGP
|
rs11244061
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr 9:133,278,537...133,278,538
|
|
Q
|
GWAS1424877_H
|
ovarian carcinoma, COVID-19 QTL GWAS1424877 (human)
|
|
IAGP
|
rs63750417
| 6.0E-16 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr17:45,983,409...45,983,410
|
|
Q
|
GWAS1425013_H
|
ovarian carcinoma, COVID-19 QTL GWAS1425013 (human)
|
|
IAGP
|
rs657152
| 6.0E-25 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr 9:133,263,862...133,263,863
|
|
Q
|
GWAS1425014_H
|
ovarian carcinoma, COVID-19 QTL GWAS1425014 (human)
|
|
IAGP
|
rs70602
| 6.0E-14 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr17:46,782,349...46,782,350
|
|
Q
|
GWAS1425015_H
|
ovarian carcinoma, COVID-19 QTL GWAS1425015 (human)
|
|
IAGP
|
rs71238846
| 2.0E-13 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr17:45,475,171...45,475,172
|
|
Q
|
GWAS1425016_H
|
ovarian carcinoma, COVID-19 QTL GWAS1425016 (human)
|
|
IAGP
|
rs199512
| 3.0E-15 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr17:46,779,986...46,779,987
|
|
Q
|
GWAS1425017_H
|
ovarian carcinoma, COVID-19 QTL GWAS1425017 (human)
|
|
IAGP
|
rs2532276
| 4.0E-13 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr17:46,169,258...46,169,259
|
|
Q
|
GWAS1428856_H
|
ovarian carcinoma QTL GWAS1428856 (human)
|
|
IAGP
|
rs2853669
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 5:1,295,234...1,295,235
|
|
Q
|
GWAS1428857_H
|
ovarian carcinoma QTL GWAS1428857 (human)
|
|
IAGP
|
rs336126
| 6.0E-11 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 5:55,180,728...55,180,729
|
|
Q
|
GWAS1429000_H
|
ovarian carcinoma QTL GWAS1429000 (human)
|
|
IAGP
|
rs2070368
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr21:34,708,100...34,708,101
|
|
Q
|
GWAS1456967_H
|
granulocyte count QTL GWAS1456967 (human)
|
|
IAGP
|
rs7679673
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 4:105,140,377...105,140,378
|
|
Q
|
GWAS1457463_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457463 (human)
|
|
IAGP
|
rs186507655
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:1,351,675...1,351,676
|
|
Q
|
GWAS1457464_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457464 (human)
|
|
IAGP
|
rs2075570
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:155,212,373...155,212,374
|
|
Q
|
GWAS1457536_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457536 (human)
|
|
IAGP
|
rs1862626
| 4.0E-12 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 5:56,737,113...56,737,114
|
|
Q
|
GWAS1457537_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457537 (human)
|
|
IAGP
|
rs147680653
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457538_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457538 (human)
|
|
IAGP
|
rs115707823
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457539_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457539 (human)
|
|
IAGP
|
rs115392158
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457540_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457540 (human)
|
|
IAGP
|
rs147527678
| 6.0E-8 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457604_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457604 (human)
|
|
IAGP
|
rs1011970
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 9:22,062,135...22,062,136
|
|
Q
|
GWAS1457605_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457605 (human)
|
|
IAGP
|
rs148883465
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr11:103,813,371...103,813,372
|
|
Q
|
GWAS1457606_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457606 (human)
|
|
IAGP
|
rs11168936
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:49,251,457...49,251,458
|
|
Q
|
GWAS1457607_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma QTL GWAS1457607 (human)
|
|
IAGP
|
rs3184504
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:111,446,804...111,446,805
|
|
Q
|
GWAS1457608_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457608 (human)
|
|
IAGP
|
rs1057941
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:155,216,951...155,216,952
|
|
Q
|
GWAS1457609_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457609 (human)
|
|
IAGP
|
rs2974935
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:155,212,052...155,212,053
|
|
Q
|
GWAS1457676_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457676 (human)
|
|
IAGP
|
rs115707823
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457677_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457677 (human)
|
|
IAGP
|
rs115392158
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457678_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457678 (human)
|
|
IAGP
|
rs147527678
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457679_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457679 (human)
|
|
IAGP
|
rs12349081
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 9:21,951,903...21,951,904
|
|
Q
|
GWAS1457680_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457680 (human)
|
|
IAGP
|
rs1011970
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 9:22,062,135...22,062,136
|
|
Q
|
GWAS1457681_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457681 (human)
|
|
IAGP
|
rs3184504
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:111,446,804...111,446,805
|
|
Q
|
GWAS1457776_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457776 (human)
|
|
IAGP
|
rs141752671
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr11:103,745,837...103,745,838
|
|
Q
|
GWAS1457777_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457777 (human)
|
|
IAGP
|
rs11065979
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:111,621,753...111,621,754
|
|
Q
|
GWAS1467225_H
|
ovarian carcinoma QTL GWAS1467225 (human)
|
|
IAGP
|
rs10088218
| 3.0E-12 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr 8:128,531,703...128,531,704
|
|
Q
|
GWAS1467226_H
|
ovarian carcinoma QTL GWAS1467226 (human)
|
|
IAGP
|
rs10088218
| 1.0E-17 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr 8:128,531,703...128,531,704
|
|
Q
|
GWAS1467227_H
|
ovarian carcinoma QTL GWAS1467227 (human)
|
|
IAGP
|
rs2072590
| 5.0E-11 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr 2:176,177,905...176,177,906
|
|
Q
|
GWAS1467228_H
|
ovarian carcinoma QTL GWAS1467228 (human)
|
|
IAGP
|
rs2072590
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr 2:176,177,905...176,177,906
|
|
Q
|
GWAS1467229_H
|
ovarian carcinoma QTL GWAS1467229 (human)
|
|
IAGP
|
rs7651446
| 2.0E-29 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr 3:156,689,208...156,689,209
|
|
Q
|
GWAS1467230_H
|
ovarian carcinoma QTL GWAS1467230 (human)
|
|
IAGP
|
rs7651446
| 2.0E-34 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr 3:156,689,208...156,689,209
|
|
Q
|
GWAS1470463_H
|
ovarian carcinoma QTL GWAS1470463 (human)
|
|
IAGP
|
rs2665390
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:20852632 |
|
NCBI chr 3:156,679,960...156,679,961
|
|
Q
|
GWAS1470464_H
|
ovarian carcinoma QTL GWAS1470464 (human)
|
|
IAGP
|
rs7521902
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:20852632 |
|
NCBI chr 1:22,164,231...22,164,232
|
|
Q
|
GWAS1470465_H
|
ovarian carcinoma QTL GWAS1470465 (human)
|
|
IAGP
|
rs2072590
| 5.0E-14 |
|
|
GWAS_CATALOG |
PMID:20852632 |
|
NCBI chr 2:176,177,905...176,177,906
|
|
Q
|
GWAS1470466_H
|
ovarian carcinoma QTL GWAS1470466 (human)
|
|
IAGP
|
rs10088218
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:20852632 |
|
NCBI chr 8:128,531,703...128,531,704
|
|
Q
|
GWAS1470523_H
|
ovarian carcinoma QTL GWAS1470523 (human)
|
|
IAGP
|
rs183211
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:23544013 |
|
NCBI chr17:46,710,944...46,710,945
|
|
Q
|
GWAS1470524_H
|
ovarian carcinoma QTL GWAS1470524 (human)
|
|
IAGP
|
rs2665390
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:23544013 |
|
NCBI chr 3:156,679,960...156,679,961
|
|
Q
|
GWAS1470525_H
|
ovarian carcinoma QTL GWAS1470525 (human)
|
|
IAGP
|
rs4691139
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:23544013 |
|
NCBI chr 4:164,987,569...164,987,570
|
|
Q
|
GWAS1477252_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477252 (human)
|
|
IAGP
|
rs1763604
| 7.0E-9 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr 1:16,013,277...16,013,278
|
|
Q
|
GWAS1477253_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477253 (human)
|
|
IAGP
|
rs13007211
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr 2:85,573,959...85,573,960
|
|
Q
|
GWAS1477254_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477254 (human)
|
|
IAGP
|
rs57251748
| 9.0E-12 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr 4:105,137,028...105,137,030
|
|
Q
|
GWAS1477255_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477255 (human)
|
|
IAGP
|
rs17762342
| 2.0E-15 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr 8:126,990,792...126,990,793
|
|
Q
|
GWAS1477256_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477256 (human)
|
|
IAGP
|
rs3802173
| 3.0E-11 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr 8:128,187,668...128,187,669
|
|
Q
|
GWAS1477257_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477257 (human)
|
|
IAGP
|
rs9657608
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr 9:21,956,231...21,956,232
|
|
Q
|
GWAS1477258_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477258 (human)
|
|
IAGP
|
rs7898685
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr10:22,010,574...22,010,575
|
|
Q
|
GWAS1477259_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477259 (human)
|
|
IAGP
|
rs568110
| 5.0E-12 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr10:113,390,512...113,390,513
|
|
Q
|
GWAS1477260_H
|
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477260 (human)
|
|
IAGP
|
rs118151305
| 6.0E-9 |
|
|
GWAS_CATALOG |
PMID:27432226 |
|
NCBI chr11:66,324,772...66,324,773
|
|
Q
|
GWAS1483232_H
|
ovarian carcinoma QTL GWAS1483232 (human)
|
|
IAGP
|
rs1400482
| 7.0E-26 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 8:128,529,685...128,529,686
|
|
Q
|
GWAS1483233_H
|
ovarian carcinoma QTL GWAS1483233 (human)
|
|
IAGP
|
rs144962376
| 4.0E-11 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
|
|
Q
|
GWAS1483450_H
|
ovarian carcinoma QTL GWAS1483450 (human)
|
|
IAGP
|
rs62274041
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 3:156,717,851...156,717,852
|
|
Q
|
GWAS1483451_H
|
ovarian carcinoma QTL GWAS1483451 (human)
|
|
IAGP
|
rs62274041
| 2.0E-57 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 3:156,717,851...156,717,852
|
|
Q
|
GWAS1483452_H
|
ovarian carcinoma QTL GWAS1483452 (human)
|
|
IAGP
|
rs6755777
| 3.0E-15 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,178,498...176,178,499
|
|
Q
|
GWAS1483453_H
|
ovarian carcinoma QTL GWAS1483453 (human)
|
|
IAGP
|
rs711830
| 3.0E-15 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,172,583...176,172,584
|
|
Q
|
GWAS1483454_H
|
ovarian carcinoma QTL GWAS1483454 (human)
|
|
IAGP
|
rs2165109
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:111,061,081...111,061,082
|
|
Q
|
GWAS1483455_H
|
ovarian carcinoma QTL GWAS1483455 (human)
|
|
IAGP
|
rs9886651
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 8:127,805,637...127,805,638
|
|
Q
|
GWAS1483456_H
|
ovarian carcinoma QTL GWAS1483456 (human)
|
|
IAGP
|
rs7953249
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr12:120,965,921...120,965,922
|
|
Q
|
GWAS1483457_H
|
ovarian carcinoma QTL GWAS1483457 (human)
|
|
IAGP
|
rs9870207
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 3:190,807,727...190,807,728
|
|
Q
|
GWAS1497353_H
|
ovarian carcinoma QTL GWAS1497353 (human)
|
|
IAGP
|
rs12031579
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 1:119,307,920...119,307,921
|
|
Q
|
GWAS1497354_H
|
ovarian carcinoma QTL GWAS1497354 (human)
|
|
IAGP
|
rs6801612
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 3:186,920,430...186,920,431
|
|
Q
|
GWAS1497355_H
|
ovarian carcinoma QTL GWAS1497355 (human)
|
|
IAGP
|
rs147867139
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 5:139,712,729...139,712,730
|
|
Q
|
GWAS1497356_H
|
ovarian carcinoma QTL GWAS1497356 (human)
|
|
IAGP
|
rs4599655
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 6:96,284,381...96,284,382
|
|
Q
|
GWAS1497357_H
|
ovarian carcinoma QTL GWAS1497357 (human)
|
|
IAGP
|
rs181474944
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 7:47,770,503...47,770,504
|
|
Q
|
GWAS1497358_H
|
ovarian carcinoma QTL GWAS1497358 (human)
|
|
IAGP
|
rs10858374
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr 9:135,247,660...135,247,661
|
|
Q
|
GWAS1497359_H
|
ovarian carcinoma QTL GWAS1497359 (human)
|
|
IAGP
|
rs789336
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr12:70,028,700...70,028,701
|
|
Q
|
GWAS1497360_H
|
ovarian carcinoma QTL GWAS1497360 (human)
|
|
IAGP
|
rs7969255
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:30557369 |
|
NCBI chr12:70,148,026...70,148,027
|
|
Q
|
GWAS1504807_H
|
breast cancer, ovarian carcinoma QTL GWAS1504807 (human)
|
|
IAGP
|
rs2290202
| 4.0E-20 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr15:90,969,037...90,969,038
|
|
Q
|
GWAS1504808_H
|
breast cancer, ovarian carcinoma QTL GWAS1504808 (human)
|
|
IAGP
|
rs35958868
| 5.0E-13 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr17:30,909,727...30,909,728
|
|
Q
|
GWAS1504809_H
|
breast cancer, ovarian carcinoma QTL GWAS1504809 (human)
|
|
IAGP
|
rs4277389
| 1.0E-23 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr17:45,818,287...45,818,288
|
|
Q
|
GWAS1504810_H
|
breast cancer, ovarian carcinoma QTL GWAS1504810 (human)
|
|
IAGP
|
rs1550623
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 2:173,348,166...173,348,167
|
|
Q
|
GWAS1504811_H
|
breast cancer, ovarian carcinoma QTL GWAS1504811 (human)
|
|
IAGP
|
rs2822991
| 6.0E-10 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr21:14,981,210...14,981,211
|
|
Q
|
GWAS1504812_H
|
breast cancer, ovarian carcinoma QTL GWAS1504812 (human)
|
|
IAGP
|
rs12233670
| 8.0E-12 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 4:38,785,595...38,785,596
|
|
Q
|
GWAS1505090_H
|
breast cancer, ovarian carcinoma QTL GWAS1505090 (human)
|
|
IAGP
|
rs4743687
| 5.0E-9 |
|
|
GWAS_CATALOG |
PMID:36819030 |
|
NCBI chr 9:104,094,629...104,094,630
|
|
Q
|
GWAS1507403_H
|
ovarian carcinoma QTL GWAS1507403 (human)
|
|
IAGP
|
rs972834
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr X:23,276,803...23,276,804
|
|
Q
|
GWAS1507721_H
|
ovarian carcinoma QTL GWAS1507721 (human)
|
|
IAGP
|
rs79219469
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr16:54,553,941...54,553,942
|
|
Q
|
GWAS1507722_H
|
ovarian carcinoma QTL GWAS1507722 (human)
|
|
IAGP
|
rs567534295
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr17:43,048,090...43,048,091
|
|
Q
|
GWAS1507723_H
|
ovarian carcinoma QTL GWAS1507723 (human)
|
|
IAGP
|
rs143623984
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 1:101,301,117...101,301,118
|
|
Q
|
GWAS1507724_H
|
ovarian carcinoma QTL GWAS1507724 (human)
|
|
IAGP
|
rs12031579
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 1:119,307,920...119,307,921
|
|
Q
|
GWAS1507725_H
|
ovarian carcinoma QTL GWAS1507725 (human)
|
|
IAGP
|
rs13402729
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 2:226,482,173...226,482,174
|
|
Q
|
GWAS1507733_H
|
ovarian carcinoma QTL GWAS1507733 (human)
|
|
IAGP
|
rs7563767
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 2:242,012,658...242,012,659
|
|
Q
|
GWAS1507734_H
|
ovarian carcinoma QTL GWAS1507734 (human)
|
|
IAGP
|
rs146572601
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 3:70,110,053...70,110,054
|
|
Q
|
GWAS1507735_H
|
ovarian carcinoma QTL GWAS1507735 (human)
|
|
IAGP
|
rs191223340
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 3:70,224,942...70,224,943
|
|
Q
|
GWAS1507736_H
|
ovarian carcinoma QTL GWAS1507736 (human)
|
|
IAGP
|
rs148570926
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 5:139,690,696...139,690,697
|
|
Q
|
GWAS1507737_H
|
ovarian carcinoma QTL GWAS1507737 (human)
|
|
IAGP
|
rs148037216
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 8:48,645,458...48,645,459
|
|
Q
|
GWAS1507738_H
|
ovarian carcinoma QTL GWAS1507738 (human)
|
|
IAGP
|
rs78375425
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr13:39,329,007...39,329,008
|
|
Q
|
GWAS1507739_H
|
ovarian carcinoma QTL GWAS1507739 (human)
|
|
IAGP
|
rs141118132
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr13:52,517,465...52,517,466
|
|
Q
|
GWAS1508041_H
|
ovarian carcinoma QTL GWAS1508041 (human)
|
|
IAGP
|
rs79219469
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr16:54,553,941...54,553,942
|
|
Q
|
GWAS1508042_H
|
ovarian carcinoma QTL GWAS1508042 (human)
|
|
IAGP
|
rs567534295
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr17:43,048,090...43,048,091
|
|
Q
|
GWAS1508043_H
|
ovarian carcinoma QTL GWAS1508043 (human)
|
|
IAGP
|
rs12031579
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 1:119,307,920...119,307,921
|
|
Q
|
GWAS1508044_H
|
ovarian carcinoma QTL GWAS1508044 (human)
|
|
IAGP
|
rs13402729
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:31488892 |
|
NCBI chr 2:226,482,173...226,482,174
|
|
Q
|
GWAS1518408_H
|
ovarian carcinoma QTL GWAS1518408 (human)
|
|
IAGP
|
rs17676711
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr 1:192,554,787...192,554,788
|
|
Q
|
GWAS1518415_H
|
ovarian carcinoma QTL GWAS1518415 (human)
|
|
IAGP
|
rs75453040
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr11:126,209,490...126,209,491
|
|
Q
|
GWAS1518416_H
|
ovarian carcinoma QTL GWAS1518416 (human)
|
|
IAGP
|
rs75214037
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34290314 |
|
NCBI chr12:127,203,336...127,203,337
|
|
Q
|
GWAS1532149_H
|
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1532149 (human)
|
|
IAGP
|
rs11621975
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr14:101,629,499...101,629,500
|
|
Q
|
GWAS1532150_H
|
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1532150 (human)
|
|
IAGP
|
rs202280
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:28935272 |
|
NCBI chr 8:81,290,982...81,290,983
|
|
Q
|
GWAS1542856_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1542856 (human)
|
|
IAGP
|
rs138544011
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 1:203,527,109...203,527,111
|
|
Q
|
GWAS1542857_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1542857 (human)
|
|
IAGP
|
rs35568631
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
|
|
Q
|
GWAS1542858_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1542858 (human)
|
|
IAGP
|
rs115721567
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 6:21,962,773...21,962,774
|
|
Q
|
GWAS1542859_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1542859 (human)
|
|
IAGP
|
rs681304
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 8:101,283,767...101,283,768
|
|
Q
|
GWAS1542860_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1542860 (human)
|
|
IAGP
|
rs11257492
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr10:6,239,119...6,239,120
|
|
Q
|
GWAS1543152_H
|
progression free survival, ovarian carcinoma QTL GWAS1543152 (human)
|
|
IAGP
|
rs6066569
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr20:47,960,104...47,960,105
|
|
Q
|
GWAS1549164_H
|
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1549164 (human)
|
|
IAGP
|
rs17338346
| 1.0E-5 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr X:31,133,020...31,133,021
|
|
Q
|
GWAS1549165_H
|
progression free survival, ovarian carcinoma QTL GWAS1549165 (human)
|
|
IAGP
|
rs1369564
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 3:177,846,247...177,846,248
|
|
Q
|
GWAS1549166_H
|
progression free survival, ovarian carcinoma QTL GWAS1549166 (human)
|
|
IAGP
|
rs146507619
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 5:67,424,965...67,424,966
|
|
Q
|
GWAS1549167_H
|
progression free survival, ovarian carcinoma QTL GWAS1549167 (human)
|
|
IAGP
|
rs1816300
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 5:97,715,297...97,715,298
|
|
Q
|
GWAS1561958_H
|
ovarian carcinoma QTL GWAS1561958 (human)
|
|
IAGP
|
rs62274041
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 3:156,717,851...156,717,852
|
|
Q
|
GWAS1561959_H
|
ovarian carcinoma QTL GWAS1561959 (human)
|
|
IAGP
|
rs4691139
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 4:164,987,569...164,987,570
|
|
Q
|
GWAS1561960_H
|
ovarian carcinoma QTL GWAS1561960 (human)
|
|
IAGP
|
rs711830
| 4.0E-14 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,172,583...176,172,584
|
|
Q
|
GWAS1561961_H
|
ovarian carcinoma QTL GWAS1561961 (human)
|
|
IAGP
|
rs6755777
| 4.0E-14 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,178,498...176,178,499
|
|
Q
|
GWAS1561962_H
|
ovarian carcinoma QTL GWAS1561962 (human)
|
|
IAGP
|
rs62274041
| 5.0E-38 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 3:156,717,851...156,717,852
|
|
Q
|
GWAS1561963_H
|
ovarian carcinoma QTL GWAS1561963 (human)
|
|
IAGP
|
rs1400482
| 7.0E-16 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 8:128,529,685...128,529,686
|
|
Q
|
GWAS1561964_H
|
ovarian carcinoma QTL GWAS1561964 (human)
|
|
IAGP
|
rs144962376
| 8.0E-10 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
|
|
Q
|
GWAS1561965_H
|
ovarian carcinoma QTL GWAS1561965 (human)
|
|
IAGP
|
rs2165109
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:111,061,081...111,061,082
|
|
Q
|
GWAS1561966_H
|
ovarian carcinoma QTL GWAS1561966 (human)
|
|
IAGP
|
rs7953249
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr12:120,965,921...120,965,922
|
|
Q
|
GWAS1565616_H
|
ovarian carcinoma QTL GWAS1565616 (human)
|
|
IAGP
|
rs113732232
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 4:176,652,990...176,652,991
|
|
Q
|
GWAS1565617_H
|
ovarian carcinoma QTL GWAS1565617 (human)
|
|
IAGP
|
rs12546957
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 8:127,619,425...127,619,426
|
|
Q
|
GWAS1565618_H
|
ovarian carcinoma QTL GWAS1565618 (human)
|
|
IAGP
|
rs13420007
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 2:44,110,941...44,110,942
|
|
Q
|
GWAS1565619_H
|
ovarian carcinoma QTL GWAS1565619 (human)
|
|
IAGP
|
rs140884924
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
|
|
Q
|
GWAS1565620_H
|
ovarian carcinoma QTL GWAS1565620 (human)
|
|
IAGP
|
rs142825068
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
|
|
Q
|
GWAS1565621_H
|
ovarian carcinoma QTL GWAS1565621 (human)
|
|
IAGP
|
rs144055451
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr17:28,302,026...28,302,027
|
|
Q
|
GWAS1565940_H
|
ovarian carcinoma QTL GWAS1565940 (human)
|
|
IAGP
|
rs145022376
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr10:1,186,288...1,186,289
|
|
Q
|
GWAS1565941_H
|
ovarian carcinoma QTL GWAS1565941 (human)
|
|
IAGP
|
rs1934363
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr10:28,484,549...28,484,550
|
|
Q
|
GWAS1565942_H
|
ovarian carcinoma QTL GWAS1565942 (human)
|
|
IAGP
|
rs7748275
| 9.0E-9 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 6:3,580,855...3,580,856
|
|
Q
|
GWAS1565943_H
|
ovarian carcinoma QTL GWAS1565943 (human)
|
|
IAGP
|
rs7748275
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 6:3,580,855...3,580,856
|
|
Q
|
GWAS1566014_H
|
ovarian carcinoma QTL GWAS1566014 (human)
|
|
IAGP
|
rs376296328
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
|
|
Q
|
GWAS1566015_H
|
ovarian carcinoma QTL GWAS1566015 (human)
|
|
IAGP
|
rs3867263
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr18:63,664,376...63,664,377
|
|
Q
|
GWAS1566016_H
|
ovarian carcinoma QTL GWAS1566016 (human)
|
|
IAGP
|
rs4936453
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr11:111,430,057...111,430,058
|
|
Q
|
GWAS1566017_H
|
ovarian carcinoma QTL GWAS1566017 (human)
|
|
IAGP
|
rs5932545
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr X:128,926,215...128,926,216
|
|
Q
|
GWAS1566018_H
|
ovarian carcinoma QTL GWAS1566018 (human)
|
|
IAGP
|
rs5993791
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr22:19,681,497...19,681,498
|
|
Q
|
GWAS1566019_H
|
ovarian carcinoma QTL GWAS1566019 (human)
|
|
IAGP
|
rs6134303
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr20:11,586,401...11,586,402
|
|
Q
|
GWAS1566020_H
|
ovarian carcinoma QTL GWAS1566020 (human)
|
|
IAGP
|
rs61658193
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 9:74,295,221...74,295,226
|
|
Q
|
GWAS1566021_H
|
ovarian carcinoma QTL GWAS1566021 (human)
|
|
IAGP
|
rs61974021
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr14:26,740,487...26,740,488
|
|
Q
|
GWAS1566022_H
|
ovarian carcinoma QTL GWAS1566022 (human)
|
|
IAGP
|
rs62397673
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 5:177,806,110...177,806,111
|
|
Q
|
GWAS1566023_H
|
ovarian carcinoma QTL GWAS1566023 (human)
|
|
IAGP
|
rs7206411
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr16:81,619,883...81,619,884
|
|
Q
|
GWAS1566025_H
|
ovarian carcinoma QTL GWAS1566025 (human)
|
|
IAGP
|
rs169225
| 7.0E-7 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr20:22,393,040...22,393,041
|
|
Q
|
GWAS1566026_H
|
ovarian carcinoma QTL GWAS1566026 (human)
|
|
IAGP
|
rs17057973
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 6:97,730,186...97,730,187
|
|
Q
|
GWAS1566027_H
|
ovarian carcinoma QTL GWAS1566027 (human)
|
|
IAGP
|
rs185652178
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 5:147,579,243...147,579,244
|
|
Q
|
GWAS1566028_H
|
ovarian carcinoma QTL GWAS1566028 (human)
|
|
IAGP
|
rs199256
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 6:143,007,986...143,007,987
|
|
Q
|
GWAS1566380_H
|
ovarian carcinoma QTL GWAS1566380 (human)
|
|
IAGP
|
rs200114742
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 4:14,172,253...14,172,254
|
|
Q
|
GWAS1566381_H
|
ovarian carcinoma QTL GWAS1566381 (human)
|
|
IAGP
|
rs200529678
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 5:87,170,215...87,170,216
|
|
Q
|
GWAS1566382_H
|
ovarian carcinoma QTL GWAS1566382 (human)
|
|
IAGP
|
rs2119438
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 4:64,932,417...64,932,418
|
|
Q
|
GWAS1566383_H
|
ovarian carcinoma QTL GWAS1566383 (human)
|
|
IAGP
|
rs28568660
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
|
|
Q
|
GWAS1566384_H
|
ovarian carcinoma QTL GWAS1566384 (human)
|
|
IAGP
|
rs34344307
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr16:77,008,511...77,008,512
|
|
Q
|
GWAS1566385_H
|
ovarian carcinoma QTL GWAS1566385 (human)
|
|
IAGP
|
rs34470775
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 5:165,518,038...165,518,039
|
|
Q
|
GWAS1566386_H
|
ovarian carcinoma QTL GWAS1566386 (human)
|
|
IAGP
|
rs3754464
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 1:159,009,146...159,009,147
|
|
Q
|
GWAS1566754_H
|
ovarian carcinoma QTL GWAS1566754 (human)
|
|
IAGP
|
rs73468194
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr X:23,151,499...23,151,500
|
|
Q
|
GWAS1566755_H
|
ovarian carcinoma QTL GWAS1566755 (human)
|
|
IAGP
|
rs74477043
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr10:80,653,667...80,653,668
|
|
Q
|
GWAS1566756_H
|
ovarian carcinoma QTL GWAS1566756 (human)
|
|
IAGP
|
rs7455465
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 7:34,585,100...34,585,101
|
|
Q
|
GWAS1566757_H
|
ovarian carcinoma QTL GWAS1566757 (human)
|
|
IAGP
|
rs74828133
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
|
|
Q
|
GWAS1566758_H
|
ovarian carcinoma QTL GWAS1566758 (human)
|
|
IAGP
|
rs74917072
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 2:238,022,053...238,022,054
|
|
Q
|
GWAS1566759_H
|
ovarian carcinoma QTL GWAS1566759 (human)
|
|
IAGP
|
rs75157307
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 2:18,193,172...18,193,173
|
|
Q
|
GWAS1567075_H
|
ovarian carcinoma QTL GWAS1567075 (human)
|
|
IAGP
|
rs7559097
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 2:38,517,625...38,517,626
|
|
Q
|
GWAS1567076_H
|
ovarian carcinoma QTL GWAS1567076 (human)
|
|
IAGP
|
rs76731728
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr10:41,850,928...41,850,929
|
|
Q
|
GWAS1567077_H
|
ovarian carcinoma QTL GWAS1567077 (human)
|
|
IAGP
|
rs77122835
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 3:116,459,821...116,459,822
|
|
Q
|
GWAS1567078_H
|
ovarian carcinoma QTL GWAS1567078 (human)
|
|
IAGP
|
rs78720768
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 1:63,315,469...63,315,470
|
|
Q
|
GWAS1567079_H
|
ovarian carcinoma QTL GWAS1567079 (human)
|
|
IAGP
|
rs79812184
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
|
|
Q
|
GWAS1567080_H
|
ovarian carcinoma QTL GWAS1567080 (human)
|
|
IAGP
|
rs8060270
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr16:73,418,955...73,418,956
|
|
Q
|
GWAS1567081_H
|
ovarian carcinoma QTL GWAS1567081 (human)
|
|
IAGP
|
rs845930
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr21:31,347,809...31,347,810
|
|
Q
|
GWAS1567082_H
|
ovarian carcinoma QTL GWAS1567082 (human)
|
|
IAGP
|
rs9382808
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 6:60,484,461...60,484,462
|
|
Q
|
GWAS1567083_H
|
ovarian carcinoma QTL GWAS1567083 (human)
|
|
IAGP
|
rs9442387
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30898391 |
|
NCBI chr 1:1,175,206...1,175,207
|
|
Q
|
GWAS1629168_H
|
ovarian carcinoma, COVID-19 QTL GWAS1629168 (human)
|
|
IAGP
|
rs4962116
| 4.0E-17 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr 9:133,254,329...133,254,330
|
|
Q
|
GWAS1629169_H
|
ovarian carcinoma, COVID-19 QTL GWAS1629169 (human)
|
|
IAGP
|
rs9411395
| 3.0E-22 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr 9:133,317,947...133,317,948
|
|
Q
|
GWAS1629170_H
|
ovarian carcinoma, COVID-19 QTL GWAS1629170 (human)
|
|
IAGP
|
rs12952950
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
NCBI chr17:45,379,403...45,379,404
|
|
Q
|
GWAS1633773_H
|
ovarian carcinoma QTL GWAS1633773 (human)
|
|
IAGP
|
rs77235147
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 8:128,970,485...128,970,486
|
|
Q
|
GWAS1694230_H
|
ovarian carcinoma, COVID-19 QTL GWAS1694230 (human)
|
|
IAGP
|
rs413917
| 8.0E-16 |
|
|
GWAS_CATALOG |
PMID:37636041 |
|
|
|
Q
|
GWAS1699711_H
|
cerebrospinal fluid composition attribute, p-tau measurement QTL GWAS1699711 (human)
|
|
IAGP
|
rs6005807
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
|
|
Q
|
GWAS559907_H
|
ovarian carcinoma QTL GWAS559907 (human)
|
|
IAGP
|
rs12794435
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:20852632 |
|
NCBI chr11:25,186,158...25,186,159
|
|
Q
|
GWAS560322_H
|
ovarian carcinoma QTL GWAS560322 (human)
|
|
IAGP
|
rs3814113
| 6.0E-11 |
|
|
GWAS_CATALOG |
PMID:23544013 |
|
NCBI chr 9:16,915,023...16,915,024
|
|
Q
|
GWAS568774_H
|
ovarian carcinoma QTL GWAS568774 (human)
|
|
IAGP
|
rs8170
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:20852633 |
|
NCBI chr19:17,278,895...17,278,896
|
|
Q
|
GWAS575657_H
|
ovarian carcinoma QTL GWAS575657 (human)
|
|
IAGP
|
rs3814113
| 5.0E-19 |
|
|
GWAS_CATALOG |
PMID:19648919 |
|
NCBI chr 9:16,915,023...16,915,024
|
|
Q
|
GWAS599694_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS599694 (human)
|
|
IAGP
|
rs4808075
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr19:17,279,482...17,279,483
|
|
Q
|
GWAS600127_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS600127 (human)
|
|
IAGP
|
rs4808075
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr19:17,279,482...17,279,483
|
|
Q
|
GWAS635401_H
|
ovarian carcinoma QTL GWAS635401 (human)
|
|
IAGP
|
rs8170
| 3.0E-14 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr19:17,278,895...17,278,896
|
|
Q
|
GWAS636026_H
|
ovarian carcinoma QTL GWAS636026 (human)
|
|
IAGP
|
rs3814113
| 4.0E-29 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr 9:16,915,023...16,915,024
|
|
Q
|
GWAS636101_H
|
ovarian carcinoma QTL GWAS636101 (human)
|
|
IAGP
|
rs8170
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr19:17,278,895...17,278,896
|
|
Q
|
GWAS636102_H
|
ovarian carcinoma QTL GWAS636102 (human)
|
|
IAGP
|
rs3814113
| 4.0E-32 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr 9:16,915,023...16,915,024
|
|
Q
|
GWAS656419_H
|
ovarian carcinoma QTL GWAS656419 (human)
|
|
IAGP
|
rs17631303
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:23544013 |
|
NCBI chr17:45,439,036...45,439,037
|
|
Q
|
GWAS667804_H
|
ovarian carcinoma QTL GWAS667804 (human)
|
|
IAGP
|
rs757210
| 8.0E-10 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr17:37,736,525...37,736,526
|
|
Q
|
GWAS669030_H
|
ovarian carcinoma QTL GWAS669030 (human)
|
|
IAGP
|
rs9303542
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:20852632 |
|
NCBI chr17:48,334,138...48,334,139
|
|
Q
|
GWAS669031_H
|
ovarian carcinoma QTL GWAS669031 (human)
|
|
IAGP
|
rs2084881
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:20852632 |
|
NCBI chr17:48,279,758...48,279,759
|
|
Q
|
GWAS674932_H
|
ovarian carcinoma QTL GWAS674932 (human)
|
|
IAGP
|
rs2363956
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:20852633 |
|
NCBI chr19:17,283,315...17,283,316
|
|
Q
|
GWAS688558_H
|
ovarian carcinoma QTL GWAS688558 (human)
|
|
IAGP
|
rs34289250
| 6.0E-13 |
|
|
GWAS_CATALOG |
PMID:21964575 |
|
NCBI chr17:61,803,285...61,803,286
|
|
Q
|
GWAS700893_H
|
ovarian carcinoma QTL GWAS700893 (human)
|
|
IAGP
|
rs9303542
| 6.0E-9 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr17:48,334,138...48,334,139
|
|
Q
|
GWAS700894_H
|
ovarian carcinoma QTL GWAS700894 (human)
|
|
IAGP
|
rs9303542
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr17:48,334,138...48,334,139
|
|
Q
|
GWAS700898_H
|
ovarian carcinoma QTL GWAS700898 (human)
|
|
IAGP
|
rs11782652
| 6.0E-9 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr 8:81,741,409...81,741,410
|
|
Q
|
GWAS700899_H
|
ovarian carcinoma QTL GWAS700899 (human)
|
|
IAGP
|
rs1243180
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr10:21,626,690...21,626,691
|
|
Q
|
GWAS700900_H
|
ovarian carcinoma QTL GWAS700900 (human)
|
|
IAGP
|
rs1243180
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr10:21,626,690...21,626,691
|
|
Q
|
GWAS700901_H
|
ovarian carcinoma QTL GWAS700901 (human)
|
|
IAGP
|
rs11782652
| 7.0E-10 |
|
|
GWAS_CATALOG |
PMID:23535730 |
|
NCBI chr 8:81,741,409...81,741,410
|
|
Q
|
GWAS726802_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS726802 (human)
|
|
IAGP
|
rs12601991
| 7.0E-28 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr17:37,741,642...37,741,643
|
|
Q
|
GWAS730995_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS730995 (human)
|
|
IAGP
|
rs12601991
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr17:37,741,642...37,741,643
|
|
|
Q
|
GWAS1117395_H
|
ovarian clear cell adenocarcinoma QTL GWAS1117395 (human)
|
|
IAGP
|
rs7405776
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:37,733,029...37,733,030
|
|
Q
|
GWAS1117396_H
|
ovarian clear cell adenocarcinoma QTL GWAS1117396 (human)
|
|
IAGP
|
rs11651755
| 7.0E-9 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:37,739,849...37,739,850
|
|
|
Q
|
GWAS1018480_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018480 (human)
|
|
IAGP
|
rs11200014
| 8.0E-35 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr10:121,575,416...121,575,417
|
|
Q
|
GWAS1018481_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018481 (human)
|
|
IAGP
|
rs7931342
| 4.0E-14 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr11:69,227,030...69,227,031
|
|
Q
|
GWAS1018549_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018549 (human)
|
|
IAGP
|
rs73110464
| 2.0E-15 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:52,918,828...52,918,829
|
|
Q
|
GWAS1018551_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018551 (human)
|
|
IAGP
|
rs11571818
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr13:32,394,673...32,394,674
|
|
Q
|
GWAS1018552_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018552 (human)
|
|
IAGP
|
rs11844632
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr14:68,559,662...68,559,663
|
|
Q
|
GWAS1018620_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018620 (human)
|
|
IAGP
|
rs11907546
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr20:34,131,991...34,131,992
|
|
Q
|
GWAS1018623_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018623 (human)
|
|
IAGP
|
rs2300206
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr20:34,002,002...34,002,003
|
|
Q
|
GWAS1018625_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018625 (human)
|
|
IAGP
|
rs56084662
| 4.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr13:32,295,727...32,295,728
|
|
Q
|
GWAS1018680_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018680 (human)
|
|
IAGP
|
rs11119608
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:210,816,167...210,816,168
|
|
Q
|
GWAS1018681_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018681 (human)
|
|
IAGP
|
rs75316749
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 3:169,043,635...169,043,636
|
|
Q
|
GWAS1018745_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018745 (human)
|
|
IAGP
|
rs4604234
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 6:80,398,959...80,398,960
|
|
Q
|
GWAS1018828_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018828 (human)
|
|
IAGP
|
rs11907546
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr20:34,131,991...34,131,992
|
|
Q
|
GWAS1018829_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018829 (human)
|
|
IAGP
|
rs2300206
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr20:34,002,002...34,002,003
|
|
Q
|
GWAS1018928_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018928 (human)
|
|
IAGP
|
rs481519
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 3:27,285,723...27,285,724
|
|
Q
|
GWAS1018929_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018929 (human)
|
|
IAGP
|
rs7725218
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 5:1,282,299...1,282,300
|
|
Q
|
GWAS1164825_H
|
lung carcinoma QTL GWAS1164825 (human)
|
|
IAGP
|
rs56404467
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr13:32,265,853...32,265,854
|
|
Q
|
GWAS1353931_H
|
family history of lung cancer QTL GWAS1353931 (human)
|
|
IAGP
|
rs11571833
| 8.0E-12 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr13:32,398,489...32,398,490
|
|
Q
|
GWAS1456967_H
|
granulocyte count QTL GWAS1456967 (human)
|
|
IAGP
|
rs7679673
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 4:105,140,377...105,140,378
|
|
Q
|
GWAS1457463_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457463 (human)
|
|
IAGP
|
rs186507655
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:1,351,675...1,351,676
|
|
Q
|
GWAS1457464_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457464 (human)
|
|
IAGP
|
rs2075570
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:155,212,373...155,212,374
|
|
Q
|
GWAS1457536_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457536 (human)
|
|
IAGP
|
rs1862626
| 4.0E-12 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 5:56,737,113...56,737,114
|
|
Q
|
GWAS1457537_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457537 (human)
|
|
IAGP
|
rs147680653
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457538_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457538 (human)
|
|
IAGP
|
rs115707823
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457539_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457539 (human)
|
|
IAGP
|
rs115392158
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457540_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457540 (human)
|
|
IAGP
|
rs147527678
| 6.0E-8 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457604_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457604 (human)
|
|
IAGP
|
rs1011970
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 9:22,062,135...22,062,136
|
|
Q
|
GWAS1457605_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457605 (human)
|
|
IAGP
|
rs148883465
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr11:103,813,371...103,813,372
|
|
Q
|
GWAS1457606_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457606 (human)
|
|
IAGP
|
rs11168936
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:49,251,457...49,251,458
|
|
Q
|
GWAS1457607_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma QTL GWAS1457607 (human)
|
|
IAGP
|
rs3184504
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:111,446,804...111,446,805
|
|
Q
|
GWAS1457608_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457608 (human)
|
|
IAGP
|
rs1057941
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:155,216,951...155,216,952
|
|
Q
|
GWAS1457609_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457609 (human)
|
|
IAGP
|
rs2974935
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:155,212,052...155,212,053
|
|
Q
|
GWAS1457676_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457676 (human)
|
|
IAGP
|
rs115707823
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457677_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457677 (human)
|
|
IAGP
|
rs115392158
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457678_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457678 (human)
|
|
IAGP
|
rs147527678
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457679_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457679 (human)
|
|
IAGP
|
rs12349081
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 9:21,951,903...21,951,904
|
|
Q
|
GWAS1457680_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457680 (human)
|
|
IAGP
|
rs1011970
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 9:22,062,135...22,062,136
|
|
Q
|
GWAS1457681_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457681 (human)
|
|
IAGP
|
rs3184504
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:111,446,804...111,446,805
|
|
Q
|
GWAS1457776_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457776 (human)
|
|
IAGP
|
rs141752671
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr11:103,745,837...103,745,838
|
|
Q
|
GWAS1457777_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457777 (human)
|
|
IAGP
|
rs11065979
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:111,621,753...111,621,754
|
|
Q
|
GWAS1483225_H
|
ovarian endometrioid carcinoma QTL GWAS1483225 (human)
|
|
IAGP
|
rs555025179
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
|
|
Q
|
GWAS599694_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS599694 (human)
|
|
IAGP
|
rs4808075
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr19:17,279,482...17,279,483
|
|
Q
|
GWAS600127_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS600127 (human)
|
|
IAGP
|
rs4808075
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr19:17,279,482...17,279,483
|
|
Q
|
GWAS726802_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS726802 (human)
|
|
IAGP
|
rs12601991
| 7.0E-28 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr17:37,741,642...37,741,643
|
|
Q
|
GWAS730995_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS730995 (human)
|
|
IAGP
|
rs12601991
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr17:37,741,642...37,741,643
|
|
|
Q
|
GWAS1116111_H
|
ovarian mucinous adenocarcinoma QTL GWAS1116111 (human)
|
|
IAGP
|
rs688187
| 7.0E-13 |
|
|
GWAS_CATALOG |
PMID:26075790 |
|
NCBI chr19:39,242,112...39,242,113
|
|
Q
|
GWAS1116129_H
|
ovarian mucinous adenocarcinoma QTL GWAS1116129 (human)
|
|
IAGP
|
rs688187
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:26075790 |
|
NCBI chr19:39,242,112...39,242,113
|
|
Q
|
GWAS1117426_H
|
ovarian mucinous adenocarcinoma QTL GWAS1117426 (human)
|
|
IAGP
|
rs112071820
| 2.0E-13 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 3:139,130,268...139,130,282
|
|
Q
|
GWAS1117428_H
|
ovarian mucinous adenocarcinoma QTL GWAS1117428 (human)
|
|
IAGP
|
rs11651755
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:37,739,849...37,739,850
|
|
Q
|
GWAS1117509_H
|
ovarian mucinous adenocarcinoma QTL GWAS1117509 (human)
|
|
IAGP
|
rs320203
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 9:102,180,944...102,180,945
|
|
Q
|
GWAS1117511_H
|
ovarian mucinous adenocarcinoma QTL GWAS1117511 (human)
|
|
IAGP
|
rs688187
| 1.0E-22 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr19:39,242,112...39,242,113
|
|
Q
|
GWAS1428254_H
|
ovarian mucinous adenocarcinoma QTL GWAS1428254 (human)
|
|
IAGP
|
rs72827480
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 2:120,388,925...120,388,926
|
|
Q
|
GWAS1483226_H
|
ovarian mucinous adenocarcinoma QTL GWAS1483226 (human)
|
|
IAGP
|
rs752590
| 2.0E-12 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:113,215,368...113,215,369
|
|
Q
|
GWAS1483227_H
|
ovarian mucinous adenocarcinoma QTL GWAS1483227 (human)
|
|
IAGP
|
rs711830
| 1.0E-14 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,172,583...176,172,584
|
|
Q
|
GWAS1483228_H
|
ovarian mucinous adenocarcinoma QTL GWAS1483228 (human)
|
|
IAGP
|
rs6755777
| 1.0E-13 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,178,498...176,178,499
|
|
Q
|
GWAS1498208_H
|
ovarian mucinous adenocarcinoma QTL GWAS1498208 (human)
|
|
IAGP
|
rs752590
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:26075790 |
|
NCBI chr 2:113,215,368...113,215,369
|
|
Q
|
GWAS1498209_H
|
ovarian mucinous adenocarcinoma QTL GWAS1498209 (human)
|
|
IAGP
|
rs711830
| 8.0E-12 |
|
|
GWAS_CATALOG |
PMID:26075790 |
|
NCBI chr 2:176,172,583...176,172,584
|
|
Q
|
GWAS1498210_H
|
ovarian mucinous adenocarcinoma QTL GWAS1498210 (human)
|
|
IAGP
|
rs72831838
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:26075790 |
|
NCBI chr 2:113,258,824...113,258,825
|
|
Q
|
GWAS1498211_H
|
ovarian mucinous adenocarcinoma QTL GWAS1498211 (human)
|
|
IAGP
|
rs711830
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:26075790 |
|
NCBI chr 2:176,172,583...176,172,584
|
|
Q
|
GWAS1615684_H
|
ovarian mucinous adenocarcinoma QTL GWAS1615684 (human)
|
|
IAGP
|
rs2594950
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 2:176,643,894...176,643,895
|
|
Q
|
GWAS1695176_H
|
ovarian mucinous adenocarcinoma QTL GWAS1695176 (human)
|
|
IAGP
|
rs6470494
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
|
|
|
Q
|
GWAS1822902_H
|
ovarian neoplasm QTL GWAS1822902 (human)
|
|
IAGP
|
rs146344777
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
|
Q
|
GWAS1428129_H
|
ovarian serous adenocarcinoma QTL GWAS1428129 (human)
|
|
IAGP
|
rs1470053
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 2:111,158,369...111,158,370
|
|
Q
|
GWAS1524125_H
|
renal carcinoma QTL GWAS1524125 (human)
|
|
IAGP
|
rs2853677
| 8.0E-10 |
|
|
GWAS_CATALOG |
PMID:38723632 |
|
NCBI chr 5:1,287,079...1,287,080
|
|
|
Q
|
GWAS1018480_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018480 (human)
|
|
IAGP
|
rs11200014
| 8.0E-35 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr10:121,575,416...121,575,417
|
|
Q
|
GWAS1018481_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018481 (human)
|
|
IAGP
|
rs7931342
| 4.0E-14 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr11:69,227,030...69,227,031
|
|
Q
|
GWAS1018549_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018549 (human)
|
|
IAGP
|
rs73110464
| 2.0E-15 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:52,918,828...52,918,829
|
|
Q
|
GWAS1018551_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018551 (human)
|
|
IAGP
|
rs11571818
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr13:32,394,673...32,394,674
|
|
Q
|
GWAS1018552_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018552 (human)
|
|
IAGP
|
rs11844632
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr14:68,559,662...68,559,663
|
|
Q
|
GWAS1018620_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018620 (human)
|
|
IAGP
|
rs11907546
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr20:34,131,991...34,131,992
|
|
Q
|
GWAS1018623_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018623 (human)
|
|
IAGP
|
rs2300206
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr20:34,002,002...34,002,003
|
|
Q
|
GWAS1018625_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018625 (human)
|
|
IAGP
|
rs56084662
| 4.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr13:32,295,727...32,295,728
|
|
Q
|
GWAS1018680_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018680 (human)
|
|
IAGP
|
rs11119608
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:210,816,167...210,816,168
|
|
Q
|
GWAS1018681_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018681 (human)
|
|
IAGP
|
rs75316749
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 3:169,043,635...169,043,636
|
|
Q
|
GWAS1018745_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018745 (human)
|
|
IAGP
|
rs4604234
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 6:80,398,959...80,398,960
|
|
Q
|
GWAS1018828_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018828 (human)
|
|
IAGP
|
rs11907546
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr20:34,131,991...34,131,992
|
|
Q
|
GWAS1018829_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018829 (human)
|
|
IAGP
|
rs2300206
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr20:34,002,002...34,002,003
|
|
Q
|
GWAS1018928_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018928 (human)
|
|
IAGP
|
rs481519
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 3:27,285,723...27,285,724
|
|
Q
|
GWAS1018929_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018929 (human)
|
|
IAGP
|
rs7725218
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 5:1,282,299...1,282,300
|
|
Q
|
GWAS1117390_H
|
ovarian carcinoma QTL GWAS1117390 (human)
|
|
IAGP
|
rs7405776
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:37,733,029...37,733,030
|
|
Q
|
GWAS1117424_H
|
ovarian serous carcinoma QTL GWAS1117424 (human)
|
|
IAGP
|
rs11651755
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:37,739,849...37,739,850
|
|
Q
|
GWAS1117430_H
|
ovarian serous carcinoma QTL GWAS1117430 (human)
|
|
IAGP
|
rs58722170
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 1:37,630,749...37,630,750
|
|
Q
|
GWAS1117504_H
|
ovarian serous carcinoma QTL GWAS1117504 (human)
|
|
IAGP
|
rs10069690
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 5:1,279,675...1,279,676
|
|
Q
|
GWAS1117505_H
|
ovarian serous carcinoma QTL GWAS1117505 (human)
|
|
IAGP
|
rs7705526
| 2.0E-20 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 5:1,285,859...1,285,860
|
|
Q
|
GWAS1117506_H
|
ovarian serous carcinoma QTL GWAS1117506 (human)
|
|
IAGP
|
rs7405776
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:37,733,029...37,733,030
|
|
Q
|
GWAS1117507_H
|
ovarian serous carcinoma QTL GWAS1117507 (human)
|
|
IAGP
|
rs7207826
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:48,423,311...48,423,312
|
|
Q
|
GWAS1117508_H
|
ovarian serous carcinoma QTL GWAS1117508 (human)
|
|
IAGP
|
rs8098244
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr18:23,825,589...23,825,590
|
|
Q
|
GWAS1117512_H
|
ovarian serous carcinoma QTL GWAS1117512 (human)
|
|
IAGP
|
rs8098244
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr18:23,825,589...23,825,590
|
|
Q
|
GWAS1117513_H
|
ovarian serous carcinoma QTL GWAS1117513 (human)
|
|
IAGP
|
rs58722170
| 8.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 1:37,630,749...37,630,750
|
|
Q
|
GWAS1117557_H
|
ovarian serous carcinoma QTL GWAS1117557 (human)
|
|
IAGP
|
rs10069690
| 5.0E-12 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 5:1,279,675...1,279,676
|
|
Q
|
GWAS1117558_H
|
ovarian serous carcinoma QTL GWAS1117558 (human)
|
|
IAGP
|
rs7705526
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 5:1,285,859...1,285,860
|
|
Q
|
GWAS1117559_H
|
ovarian serous carcinoma QTL GWAS1117559 (human)
|
|
IAGP
|
rs10962692
| 1.0E-47 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 9:16,915,876...16,915,877
|
|
Q
|
GWAS1117560_H
|
ovarian serous carcinoma QTL GWAS1117560 (human)
|
|
IAGP
|
rs4742903
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 9:104,094,512...104,094,513
|
|
Q
|
GWAS1117561_H
|
ovarian serous carcinoma QTL GWAS1117561 (human)
|
|
IAGP
|
rs8037137
| 7.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr15:90,963,407...90,963,408
|
|
Q
|
GWAS1117562_H
|
ovarian serous carcinoma QTL GWAS1117562 (human)
|
|
IAGP
|
rs7405776
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:37,733,029...37,733,030
|
|
Q
|
GWAS1117563_H
|
ovarian serous carcinoma QTL GWAS1117563 (human)
|
|
IAGP
|
rs11651755
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:37,739,849...37,739,850
|
|
Q
|
GWAS1117564_H
|
ovarian serous carcinoma QTL GWAS1117564 (human)
|
|
IAGP
|
rs7207826
| 8.0E-14 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:48,423,311...48,423,312
|
|
Q
|
GWAS1117565_H
|
ovarian serous carcinoma QTL GWAS1117565 (human)
|
|
IAGP
|
rs4808075
| 3.0E-26 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr19:17,279,482...17,279,483
|
|
Q
|
GWAS1117566_H
|
ovarian serous carcinoma QTL GWAS1117566 (human)
|
|
IAGP
|
rs1879586
| 3.0E-13 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:45,489,971...45,489,972
|
|
Q
|
GWAS1117567_H
|
ovarian serous carcinoma QTL GWAS1117567 (human)
|
|
IAGP
|
rs6005807
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr22:28,538,325...28,538,326
|
|
Q
|
GWAS1117568_H
|
ovarian serous carcinoma QTL GWAS1117568 (human)
|
|
IAGP
|
rs10069690
| 2.0E-12 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 5:1,279,675...1,279,676
|
|
Q
|
GWAS1117569_H
|
ovarian serous carcinoma QTL GWAS1117569 (human)
|
|
IAGP
|
rs7705526
| 6.0E-10 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 5:1,285,859...1,285,860
|
|
Q
|
GWAS1117623_H
|
ovarian serous carcinoma QTL GWAS1117623 (human)
|
|
IAGP
|
rs10962692
| 3.0E-43 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 9:16,915,876...16,915,877
|
|
Q
|
GWAS1117624_H
|
ovarian serous carcinoma QTL GWAS1117624 (human)
|
|
IAGP
|
rs8037137
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr15:90,963,407...90,963,408
|
|
Q
|
GWAS1117625_H
|
ovarian serous carcinoma QTL GWAS1117625 (human)
|
|
IAGP
|
rs11651755
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:37,739,849...37,739,850
|
|
Q
|
GWAS1117626_H
|
ovarian serous carcinoma QTL GWAS1117626 (human)
|
|
IAGP
|
rs1879586
| 3.0E-12 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:45,489,971...45,489,972
|
|
Q
|
GWAS1117627_H
|
ovarian serous carcinoma QTL GWAS1117627 (human)
|
|
IAGP
|
rs7207826
| 1.0E-14 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:48,423,311...48,423,312
|
|
Q
|
GWAS1117628_H
|
ovarian serous carcinoma QTL GWAS1117628 (human)
|
|
IAGP
|
rs4808075
| 4.0E-24 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr19:17,279,482...17,279,483
|
|
Q
|
GWAS1117629_H
|
ovarian serous carcinoma QTL GWAS1117629 (human)
|
|
IAGP
|
rs6005807
| 5.0E-9 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr22:28,538,325...28,538,326
|
|
Q
|
GWAS1117630_H
|
ovarian serous carcinoma QTL GWAS1117630 (human)
|
|
IAGP
|
rs13113999
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 4:166,265,894...166,265,895
|
|
Q
|
GWAS1117631_H
|
ovarian serous carcinoma QTL GWAS1117631 (human)
|
|
IAGP
|
rs10069690
| 4.0E-9 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 5:1,279,675...1,279,676
|
|
Q
|
GWAS1117633_H
|
ovarian serous carcinoma QTL GWAS1117633 (human)
|
|
IAGP
|
rs11651755
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:37,739,849...37,739,850
|
|
Q
|
GWAS1117634_H
|
ovarian serous carcinoma QTL GWAS1117634 (human)
|
|
IAGP
|
rs7207826
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr17:48,423,311...48,423,312
|
|
Q
|
GWAS1164825_H
|
lung carcinoma QTL GWAS1164825 (human)
|
|
IAGP
|
rs56404467
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr13:32,265,853...32,265,854
|
|
Q
|
GWAS1242108_H
|
response to gemcitabine QTL GWAS1242108 (human)
|
|
IAGP
|
rs11141915
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 9:87,620,879...87,620,880
|
|
Q
|
GWAS1339505_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1339505 (human)
|
|
IAGP
|
rs35241450
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr22:29,117,567...29,117,568
|
|
Q
|
GWAS1340188_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340188 (human)
|
|
IAGP
|
rs2376820
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 1:3,092,123...3,092,124
|
|
Q
|
GWAS1340189_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340189 (human)
|
|
IAGP
|
rs147138325
| 1.0E-5 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 1:65,863,804...65,863,805
|
|
Q
|
GWAS1340190_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340190 (human)
|
|
IAGP
|
rs77652838
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 2:47,011,089...47,011,090
|
|
Q
|
GWAS1340191_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340191 (human)
|
|
IAGP
|
rs17018999
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 2:80,340,409...80,340,410
|
|
Q
|
GWAS1340192_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340192 (human)
|
|
IAGP
|
rs117774911
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 2:136,288,123...136,288,124
|
|
Q
|
GWAS1340193_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340193 (human)
|
|
IAGP
|
rs74801337
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 3:76,485,727...76,485,728
|
|
Q
|
GWAS1340194_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340194 (human)
|
|
IAGP
|
rs143886976
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 3:89,297,772...89,297,773
|
|
Q
|
GWAS1340195_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340195 (human)
|
|
IAGP
|
rs59152766
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 5:59,531,580...59,531,581
|
|
Q
|
GWAS1340196_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340196 (human)
|
|
IAGP
|
rs35893266
| 6.0E-7 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 5:76,450,735...76,450,736
|
|
Q
|
GWAS1340197_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340197 (human)
|
|
IAGP
|
rs7738568
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 6:64,953,580...64,953,581
|
|
Q
|
GWAS1340198_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340198 (human)
|
|
IAGP
|
rs78503057
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 7:23,357,410...23,357,411
|
|
Q
|
GWAS1340199_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340199 (human)
|
|
IAGP
|
rs111401235
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 7:95,515,509...95,515,510
|
|
Q
|
GWAS1340351_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340351 (human)
|
|
IAGP
|
rs142620543
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 9:12,865,681...12,865,682
|
|
Q
|
GWAS1340352_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340352 (human)
|
|
IAGP
|
rs74865532
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 9:126,858,271...126,858,272
|
|
Q
|
GWAS1340353_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340353 (human)
|
|
IAGP
|
rs1323657
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr10:6,030,464...6,030,465
|
|
Q
|
GWAS1341204_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341204 (human)
|
|
IAGP
|
rs151311539
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr11:25,650,835...25,650,836
|
|
Q
|
GWAS1341205_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341205 (human)
|
|
IAGP
|
rs11323103
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr11:35,219,864...35,219,865
|
|
Q
|
GWAS1341206_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341206 (human)
|
|
IAGP
|
rs11450161
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr13:35,896,591...35,896,592
|
|
Q
|
GWAS1341374_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341374 (human)
|
|
IAGP
|
rs28538685
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr15:100,153,308...100,153,309
|
|
Q
|
GWAS1341375_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341375 (human)
|
|
IAGP
|
rs35925564
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr16:9,015,221...9,015,222
|
|
Q
|
GWAS1341376_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341376 (human)
|
|
IAGP
|
rs148873983
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr18:65,675,931...65,675,932
|
|
Q
|
GWAS1341377_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341377 (human)
|
|
IAGP
|
rs140397425
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr21:38,573,750...38,573,751
|
|
Q
|
GWAS1341378_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341378 (human)
|
|
IAGP
|
rs116481116
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr22:25,815,823...25,815,824
|
|
Q
|
GWAS1341379_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341379 (human)
|
|
IAGP
|
rs5752640
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr22:27,807,762...27,807,763
|
|
Q
|
GWAS1341380_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1341380 (human)
|
|
IAGP
|
rs183171911
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 2:36,756,075...36,756,076
|
|
Q
|
GWAS1341381_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1341381 (human)
|
|
IAGP
|
rs56928399
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 2:80,339,512...80,339,513
|
|
Q
|
GWAS1341382_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1341382 (human)
|
|
IAGP
|
rs1875108
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 3:55,592,887...55,592,888
|
|
Q
|
GWAS1341383_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1341383 (human)
|
|
IAGP
|
rs10595258
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 6:48,070,151...48,070,152
|
|
Q
|
GWAS1341384_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1341384 (human)
|
|
IAGP
|
rs35878068
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 7:48,200,990...48,200,995
|
|
Q
|
GWAS1341385_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1341385 (human)
|
|
IAGP
|
rs13238345
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 7:108,471,296...108,471,297
|
|
Q
|
GWAS1342141_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1342141 (human)
|
|
IAGP
|
rs111774916
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 8:53,908,184...53,908,185
|
|
Q
|
GWAS1342142_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1342142 (human)
|
|
IAGP
|
rs74855156
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 9:4,460,023...4,460,024
|
|
Q
|
GWAS1342143_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1342143 (human)
|
|
IAGP
|
rs202172222
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr15:41,722,120...41,722,121
|
|
Q
|
GWAS1353931_H
|
family history of lung cancer QTL GWAS1353931 (human)
|
|
IAGP
|
rs11571833
| 8.0E-12 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr13:32,398,489...32,398,490
|
|
Q
|
GWAS1456967_H
|
granulocyte count QTL GWAS1456967 (human)
|
|
IAGP
|
rs7679673
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 4:105,140,377...105,140,378
|
|
Q
|
GWAS1457463_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457463 (human)
|
|
IAGP
|
rs186507655
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:1,351,675...1,351,676
|
|
Q
|
GWAS1457464_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457464 (human)
|
|
IAGP
|
rs2075570
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:155,212,373...155,212,374
|
|
Q
|
GWAS1457536_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457536 (human)
|
|
IAGP
|
rs1862626
| 4.0E-12 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 5:56,737,113...56,737,114
|
|
Q
|
GWAS1457537_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457537 (human)
|
|
IAGP
|
rs147680653
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457538_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457538 (human)
|
|
IAGP
|
rs115707823
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457539_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457539 (human)
|
|
IAGP
|
rs115392158
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457540_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457540 (human)
|
|
IAGP
|
rs147527678
| 6.0E-8 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457604_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457604 (human)
|
|
IAGP
|
rs1011970
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 9:22,062,135...22,062,136
|
|
Q
|
GWAS1457605_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457605 (human)
|
|
IAGP
|
rs148883465
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr11:103,813,371...103,813,372
|
|
Q
|
GWAS1457606_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457606 (human)
|
|
IAGP
|
rs11168936
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:49,251,457...49,251,458
|
|
Q
|
GWAS1457607_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma QTL GWAS1457607 (human)
|
|
IAGP
|
rs3184504
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:111,446,804...111,446,805
|
|
Q
|
GWAS1457608_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457608 (human)
|
|
IAGP
|
rs1057941
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:155,216,951...155,216,952
|
|
Q
|
GWAS1457609_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457609 (human)
|
|
IAGP
|
rs2974935
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 1:155,212,052...155,212,053
|
|
Q
|
GWAS1457676_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457676 (human)
|
|
IAGP
|
rs115707823
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457677_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457677 (human)
|
|
IAGP
|
rs115392158
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457678_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457678 (human)
|
|
IAGP
|
rs147527678
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
|
|
Q
|
GWAS1457679_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457679 (human)
|
|
IAGP
|
rs12349081
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 9:21,951,903...21,951,904
|
|
Q
|
GWAS1457680_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457680 (human)
|
|
IAGP
|
rs1011970
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr 9:22,062,135...22,062,136
|
|
Q
|
GWAS1457681_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457681 (human)
|
|
IAGP
|
rs3184504
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:111,446,804...111,446,805
|
|
Q
|
GWAS1457776_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457776 (human)
|
|
IAGP
|
rs141752671
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr11:103,745,837...103,745,838
|
|
Q
|
GWAS1457777_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457777 (human)
|
|
IAGP
|
rs11065979
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr12:111,621,753...111,621,754
|
|
Q
|
GWAS1461488_H
|
ovarian serous carcinoma QTL GWAS1461488 (human)
|
|
IAGP
|
rs57403204
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:31469419 |
|
NCBI chr X:141,990,766...141,990,767
|
|
Q
|
GWAS1461489_H
|
ovarian serous carcinoma QTL GWAS1461489 (human)
|
|
IAGP
|
rs66459581
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:31469419 |
|
NCBI chr17:76,359,183...76,359,184
|
|
Q
|
GWAS1483222_H
|
ovarian serous carcinoma QTL GWAS1483222 (human)
|
|
IAGP
|
rs9870207
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 3:190,807,727...190,807,728
|
|
Q
|
GWAS1483223_H
|
ovarian serous carcinoma QTL GWAS1483223 (human)
|
|
IAGP
|
rs1400482
| 1.0E-16 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 8:128,529,685...128,529,686
|
|
Q
|
GWAS1483224_H
|
ovarian serous carcinoma QTL GWAS1483224 (human)
|
|
IAGP
|
rs7902587
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr10:103,934,543...103,934,544
|
|
Q
|
GWAS1483229_H
|
ovarian serous carcinoma QTL GWAS1483229 (human)
|
|
IAGP
|
rs711830
| 3.0E-14 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,172,583...176,172,584
|
|
Q
|
GWAS1483230_H
|
ovarian serous carcinoma QTL GWAS1483230 (human)
|
|
IAGP
|
rs6755777
| 2.0E-14 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,178,498...176,178,499
|
|
Q
|
GWAS1483231_H
|
ovarian serous carcinoma QTL GWAS1483231 (human)
|
|
IAGP
|
rs6755777
| 6.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,178,498...176,178,499
|
|
Q
|
GWAS1483234_H
|
ovarian serous carcinoma QTL GWAS1483234 (human)
|
|
IAGP
|
rs150293538
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 8:76,408,119...76,408,120
|
|
Q
|
GWAS1483449_H
|
ovarian serous carcinoma QTL GWAS1483449 (human)
|
|
IAGP
|
rs711830
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,172,583...176,172,584
|
|
Q
|
GWAS1535271_H
|
ovarian serous carcinoma QTL GWAS1535271 (human)
|
|
IAGP
|
rs62274041
| 3.0E-46 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 3:156,717,851...156,717,852
|
|
Q
|
GWAS1535272_H
|
ovarian serous carcinoma QTL GWAS1535272 (human)
|
|
IAGP
|
rs1400482
| 2.0E-24 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 8:128,529,685...128,529,686
|
|
Q
|
GWAS1535273_H
|
ovarian serous carcinoma QTL GWAS1535273 (human)
|
|
IAGP
|
rs144962376
| 7.0E-9 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
|
|
Q
|
GWAS1535274_H
|
ovarian serous carcinoma QTL GWAS1535274 (human)
|
|
IAGP
|
rs2165109
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:111,061,081...111,061,082
|
|
Q
|
GWAS1535278_H
|
ovarian serous carcinoma QTL GWAS1535278 (human)
|
|
IAGP
|
rs6755777
| 5.0E-13 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,178,498...176,178,499
|
|
Q
|
GWAS1535279_H
|
ovarian serous carcinoma QTL GWAS1535279 (human)
|
|
IAGP
|
rs62274041
| 4.0E-49 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 3:156,717,851...156,717,852
|
|
Q
|
GWAS1535280_H
|
ovarian serous carcinoma QTL GWAS1535280 (human)
|
|
IAGP
|
rs1400482
| 7.0E-22 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 8:128,529,685...128,529,686
|
|
Q
|
GWAS1535281_H
|
ovarian serous carcinoma QTL GWAS1535281 (human)
|
|
IAGP
|
rs144962376
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
|
|
Q
|
GWAS1535282_H
|
ovarian serous carcinoma QTL GWAS1535282 (human)
|
|
IAGP
|
rs7953249
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr12:120,965,921...120,965,922
|
|
Q
|
GWAS1535360_H
|
ovarian serous carcinoma QTL GWAS1535360 (human)
|
|
IAGP
|
rs150293538
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 8:76,408,119...76,408,120
|
|
Q
|
GWAS1535361_H
|
ovarian serous carcinoma QTL GWAS1535361 (human)
|
|
IAGP
|
rs711830
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,172,583...176,172,584
|
|
Q
|
GWAS1535362_H
|
ovarian serous carcinoma QTL GWAS1535362 (human)
|
|
IAGP
|
rs6755777
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,178,498...176,178,499
|
|
Q
|
GWAS1535363_H
|
ovarian serous carcinoma QTL GWAS1535363 (human)
|
|
IAGP
|
rs711830
| 8.0E-13 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 2:176,172,583...176,172,584
|
|
Q
|
GWAS1535364_H
|
ovarian serous carcinoma QTL GWAS1535364 (human)
|
|
IAGP
|
rs9886651
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 8:127,805,637...127,805,638
|
|
Q
|
GWAS1535365_H
|
ovarian serous carcinoma QTL GWAS1535365 (human)
|
|
IAGP
|
rs7953249
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr12:120,965,921...120,965,922
|
|
Q
|
GWAS1535367_H
|
ovarian serous carcinoma QTL GWAS1535367 (human)
|
|
IAGP
|
rs1400482
| 2.0E-12 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr 8:128,529,685...128,529,686
|
|
Q
|
GWAS1535368_H
|
ovarian serous carcinoma QTL GWAS1535368 (human)
|
|
IAGP
|
rs7902587
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
NCBI chr10:103,934,543...103,934,544
|
|
Q
|
GWAS1542861_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1542861 (human)
|
|
IAGP
|
rs1369564
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 3:177,846,247...177,846,248
|
|
Q
|
GWAS1542862_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1542862 (human)
|
|
IAGP
|
rs9841147
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 3:197,379,538...197,379,539
|
|
Q
|
GWAS1543149_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1543149 (human)
|
|
IAGP
|
rs116521001
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 4:4,870,660...4,870,661
|
|
Q
|
GWAS1543150_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1543150 (human)
|
|
IAGP
|
rs1816300
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 5:97,715,297...97,715,298
|
|
Q
|
GWAS1543151_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1543151 (human)
|
|
IAGP
|
rs6479436
| 7.0E-7 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 9:92,905,580...92,905,581
|
|
Q
|
GWAS1543153_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1543153 (human)
|
|
IAGP
|
rs376435808
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr13:24,364,286...24,364,287
|
|
Q
|
GWAS1543154_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1543154 (human)
|
|
IAGP
|
rs138082585
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
|
|
Q
|
GWAS1543155_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1543155 (human)
|
|
IAGP
|
rs4898923
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr14:57,015,823...57,015,824
|
|
Q
|
GWAS1543156_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1543156 (human)
|
|
IAGP
|
rs62337885
| 7.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 4:173,772,135...173,772,136
|
|
Q
|
GWAS1543157_H
|
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1543157 (human)
|
|
IAGP
|
rs7821642
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr 8:19,785,969...19,785,970
|
|
Q
|
GWAS1543165_H
|
progression free survival, ovarian serous carcinoma QTL GWAS1543165 (human)
|
|
IAGP
|
rs80077319
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:34162658 |
|
NCBI chr20:24,332,133...24,332,134
|
|
Q
|
GWAS1698914_H
|
myeloid leukocyte count QTL GWAS1698914 (human)
|
|
IAGP
|
rs7705526
| 6.0E-19 |
|
|
GWAS_CATALOG |
PMID:28346442 |
|
|
|
Q
|
GWAS599694_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS599694 (human)
|
|
IAGP
|
rs4808075
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr19:17,279,482...17,279,483
|
|
Q
|
GWAS600127_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS600127 (human)
|
|
IAGP
|
rs4808075
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr19:17,279,482...17,279,483
|
|
Q
|
GWAS719484_H
|
ovarian serous carcinoma QTL GWAS719484 (human)
|
|
IAGP
|
rs37792
| 6.0E-8 |
|
|
GWAS_CATALOG |
PMID:31469419 |
|
NCBI chr 5:53,348,817...53,348,818
|
|
Q
|
GWAS719486_H
|
ovarian serous carcinoma QTL GWAS719486 (human)
|
|
IAGP
|
rs79079890
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:31469419 |
|
NCBI chr10:3,641,956...3,641,957
|
|
Q
|
GWAS726802_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS726802 (human)
|
|
IAGP
|
rs12601991
| 7.0E-28 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr17:37,741,642...37,741,643
|
|
Q
|
GWAS730995_H
|
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS730995 (human)
|
|
IAGP
|
rs12601991
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:27197191 |
|
NCBI chr17:37,741,642...37,741,643
|
|
Q
|
GWAS765114_H
|
ovarian serous carcinoma QTL GWAS765114 (human)
|
|
IAGP
|
rs116046250
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:31469419 |
|
NCBI chr15:26,986,803...26,986,804
|
|
Q
|
GWAS765115_H
|
ovarian serous carcinoma QTL GWAS765115 (human)
|
|
IAGP
|
rs192876988
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:31469419 |
|
NCBI chr 4:79,376,097...79,376,098
|
|
|
Q
|
GWAS1116453_H
|
polycystic ovary syndrome QTL GWAS1116453 (human)
|
|
IAGP
|
rs7563201
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:26416764 |
|
NCBI chr 2:43,334,641...43,334,642
|
|
Q
|
GWAS1116454_H
|
polycystic ovary syndrome QTL GWAS1116454 (human)
|
|
IAGP
|
rs1351592
| 1.0E-12 |
|
|
GWAS_CATALOG |
PMID:26416764 |
|
NCBI chr 2:212,529,988...212,529,989
|
|
Q
|
GWAS1116455_H
|
polycystic ovary syndrome QTL GWAS1116455 (human)
|
|
IAGP
|
rs11225154
| 8.0E-11 |
|
|
GWAS_CATALOG |
PMID:26416764 |
|
NCBI chr11:102,172,509...102,172,510
|
|
Q
|
GWAS1116456_H
|
polycystic ovary syndrome QTL GWAS1116456 (human)
|
|
IAGP
|
rs1275468
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:26416764 |
|
NCBI chr12:75,541,377...75,541,378
|
|
Q
|
GWAS1116457_H
|
polycystic ovary syndrome QTL GWAS1116457 (human)
|
|
IAGP
|
rs7312770
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:26416764 |
|
NCBI chr12:56,073,803...56,073,804
|
|
Q
|
GWAS1170454_H
|
polycystic ovary syndrome QTL GWAS1170454 (human)
|
|
IAGP
|
rs10986105
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:26284813 |
|
NCBI chr 9:123,787,676...123,787,677
|
|
Q
|
GWAS1170455_H
|
polycystic ovary syndrome QTL GWAS1170455 (human)
|
|
IAGP
|
rs7574059
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:26284813 |
|
NCBI chr 2:123,613,428...123,613,429
|
|
Q
|
GWAS1170456_H
|
polycystic ovary syndrome QTL GWAS1170456 (human)
|
|
IAGP
|
rs10993397
| 5.0E-13 |
|
|
GWAS_CATALOG |
PMID:26284813 |
|
NCBI chr 9:94,917,489...94,917,490
|
|
Q
|
GWAS1170457_H
|
polycystic ovary syndrome QTL GWAS1170457 (human)
|
|
IAGP
|
rs1784692
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:26284813 |
|
NCBI chr11:114,078,510...114,078,511
|
|
Q
|
GWAS1210193_H
|
polycystic ovary syndrome QTL GWAS1210193 (human)
|
|
IAGP
|
rs7563201
| 4.0E-10 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr 2:43,334,641...43,334,642
|
|
Q
|
GWAS1210194_H
|
polycystic ovary syndrome QTL GWAS1210194 (human)
|
|
IAGP
|
rs2178575
| 3.0E-14 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr 2:212,527,042...212,527,043
|
|
Q
|
GWAS1210195_H
|
polycystic ovary syndrome QTL GWAS1210195 (human)
|
|
IAGP
|
rs10739076
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr 9:5,440,589...5,440,590
|
|
Q
|
GWAS1210387_H
|
polycystic ovary syndrome QTL GWAS1210387 (human)
|
|
IAGP
|
rs7864171
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr 9:94,960,984...94,960,985
|
|
Q
|
GWAS1210388_H
|
polycystic ovary syndrome QTL GWAS1210388 (human)
|
|
IAGP
|
rs9696009
| 8.0E-11 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr 9:123,856,954...123,856,955
|
|
Q
|
GWAS1210389_H
|
polycystic ovary syndrome QTL GWAS1210389 (human)
|
|
IAGP
|
rs11225154
| 5.0E-11 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr11:102,172,509...102,172,510
|
|
Q
|
GWAS1210390_H
|
polycystic ovary syndrome QTL GWAS1210390 (human)
|
|
IAGP
|
rs1784692
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr11:114,078,510...114,078,511
|
|
Q
|
GWAS1210391_H
|
polycystic ovary syndrome QTL GWAS1210391 (human)
|
|
IAGP
|
rs2271194
| 5.0E-9 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr12:56,083,910...56,083,911
|
|
Q
|
GWAS1210392_H
|
polycystic ovary syndrome QTL GWAS1210392 (human)
|
|
IAGP
|
rs1795379
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr12:75,547,262...75,547,263
|
|
Q
|
GWAS1210393_H
|
polycystic ovary syndrome QTL GWAS1210393 (human)
|
|
IAGP
|
rs853854
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr20:32,832,951...32,832,952
|
|
Q
|
GWAS1211074_H
|
polycystic ovary syndrome QTL GWAS1211074 (human)
|
|
IAGP
|
rs12450465
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:30343302 |
|
NCBI chr17:33,053,293...33,053,294
|
|
Q
|
GWAS1211075_H
|
polycystic ovary syndrome QTL GWAS1211075 (human)
|
|
IAGP
|
rs2060941
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:30343302 |
|
NCBI chr17:39,826,630...39,826,631
|
|
Q
|
GWAS1336996_H
|
polycystic ovary syndrome, type 2 diabetes mellitus QTL GWAS1336996 (human)
|
|
IAGP
|
rs8050136
| 2E-85 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
NCBI chr16:53,782,363...53,782,364
|
|
Q
|
GWAS1336997_H
|
polycystic ovary syndrome, type 2 diabetes mellitus QTL GWAS1336997 (human)
|
|
IAGP
|
rs9675376
| 4.0E-10 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
NCBI chr18:60,302,011...60,302,012
|
|
Q
|
GWAS1336998_H
|
polycystic ovary syndrome, type 2 diabetes mellitus QTL GWAS1336998 (human)
|
|
IAGP
|
rs72753599
| 4.0E-13 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
NCBI chr 1:214,007,176...214,007,177
|
|
Q
|
GWAS1336999_H
|
polycystic ovary syndrome, type 2 diabetes mellitus QTL GWAS1336999 (human)
|
|
IAGP
|
rs10938398
| 1.0E-12 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
NCBI chr 4:45,184,122...45,184,123
|
|
Q
|
GWAS1337000_H
|
polycystic ovary syndrome, type 2 diabetes mellitus QTL GWAS1337000 (human)
|
|
IAGP
|
rs9930501
| 6.0E-15 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
NCBI chr16:53,796,540...53,796,541
|
|
Q
|
GWAS1337001_H
|
polycystic ovary syndrome, type 2 diabetes mellitus QTL GWAS1337001 (human)
|
|
IAGP
|
rs72753599
| 6.0E-14 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
NCBI chr 1:214,007,176...214,007,177
|
|
Q
|
GWAS1337002_H
|
polycystic ovary syndrome, type 2 diabetes mellitus QTL GWAS1337002 (human)
|
|
IAGP
|
rs3934729
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
NCBI chr 3:123,300,916...123,300,917
|
|
Q
|
GWAS1337225_H
|
HbA1c measurement, polycystic ovary syndrome QTL GWAS1337225 (human)
|
|
IAGP
|
rs8047587
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
NCBI chr16:53,764,710...53,764,711
|
|
Q
|
GWAS1393235_H
|
polycystic ovary syndrome QTL GWAS1393235 (human)
|
|
IAGP
|
rs182075939
| 2.0E-16 |
|
|
GWAS_CATALOG |
PMID:34791234 |
|
NCBI chr22:28,702,388...28,702,389
|
|
Q
|
GWAS1393236_H
|
polycystic ovary syndrome QTL GWAS1393236 (human)
|
|
IAGP
|
rs7564590
| 5.0E-9 |
|
|
GWAS_CATALOG |
PMID:34791234 |
|
NCBI chr 2:212,523,176...212,523,177
|
|
Q
|
GWAS1393237_H
|
polycystic ovary syndrome QTL GWAS1393237 (human)
|
|
IAGP
|
rs9312937
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:34791234 |
|
NCBI chr 5:16,835,896...16,835,897
|
|
Q
|
GWAS1393238_H
|
polycystic ovary syndrome QTL GWAS1393238 (human)
|
|
IAGP
|
rs3945628
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:34791234 |
|
NCBI chr 9:123,773,274...123,773,275
|
|
Q
|
GWAS1393239_H
|
polycystic ovary syndrome QTL GWAS1393239 (human)
|
|
IAGP
|
rs1672716
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:34791234 |
|
NCBI chr11:114,081,775...114,081,776
|
|
Q
|
GWAS1393240_H
|
polycystic ovary syndrome QTL GWAS1393240 (human)
|
|
IAGP
|
rs182075939
| 5.0E-14 |
|
|
GWAS_CATALOG |
PMID:34791234 |
|
NCBI chr22:28,702,388...28,702,389
|
|
Q
|
GWAS1394090_H
|
polycystic ovary syndrome QTL GWAS1394090 (human)
|
|
IAGP
|
rs7564590
| 5.0E-11 |
|
|
GWAS_CATALOG |
PMID:34791234 |
|
NCBI chr 2:212,523,176...212,523,177
|
|
Q
|
GWAS1394091_H
|
polycystic ovary syndrome QTL GWAS1394091 (human)
|
|
IAGP
|
rs9312937
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:34791234 |
|
NCBI chr 5:16,835,896...16,835,897
|
|
Q
|
GWAS1394092_H
|
polycystic ovary syndrome QTL GWAS1394092 (human)
|
|
IAGP
|
rs3945628
| 3.0E-12 |
|
|
GWAS_CATALOG |
PMID:34791234 |
|
NCBI chr 9:123,773,274...123,773,275
|
|
Q
|
GWAS1394093_H
|
polycystic ovary syndrome QTL GWAS1394093 (human)
|
|
IAGP
|
rs1672716
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:34791234 |
|
NCBI chr11:114,081,775...114,081,776
|
|
Q
|
GWAS1394094_H
|
polycystic ovary syndrome QTL GWAS1394094 (human)
|
|
IAGP
|
rs145598156
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:34791234 |
|
NCBI chr22:29,020,414...29,020,415
|
|
Q
|
GWAS1465991_H
|
polycystic ovary syndrome QTL GWAS1465991 (human)
|
|
IAGP
|
rs10835638
| 5.0E-12 |
|
|
GWAS_CATALOG |
PMID:32574161 |
|
NCBI chr11:30,230,805...30,230,806
|
|
Q
|
GWAS1468011_H
|
polycystic ovary syndrome QTL GWAS1468011 (human)
|
|
IAGP
|
rs17186366
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:32289280 |
|
NCBI chr 6:159,477,229...159,477,230
|
|
Q
|
GWAS1468557_H
|
polycystic ovary syndrome QTL GWAS1468557 (human)
|
|
IAGP
|
rs705702
| 9.0E-26 |
|
|
GWAS_CATALOG |
PMID:22885925 |
|
NCBI chr12:55,996,852...55,996,853
|
|
Q
|
GWAS1468558_H
|
polycystic ovary syndrome QTL GWAS1468558 (human)
|
|
IAGP
|
rs4784165
| 4.0E-11 |
|
|
GWAS_CATALOG |
PMID:22885925 |
|
NCBI chr16:52,313,907...52,313,908
|
|
Q
|
GWAS1468559_H
|
polycystic ovary syndrome QTL GWAS1468559 (human)
|
|
IAGP
|
rs6022786
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:22885925 |
|
NCBI chr20:53,830,764...53,830,765
|
|
Q
|
GWAS1471106_H
|
polycystic ovary syndrome QTL GWAS1471106 (human)
|
|
IAGP
|
rs78025940
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:32574161 |
|
NCBI chr 1:14,404,304...14,404,305
|
|
Q
|
GWAS1471107_H
|
polycystic ovary syndrome QTL GWAS1471107 (human)
|
|
IAGP
|
rs76182733
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:32574161 |
|
NCBI chr 2:236,518,238...236,518,239
|
|
Q
|
GWAS1471108_H
|
polycystic ovary syndrome QTL GWAS1471108 (human)
|
|
IAGP
|
rs11031006
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:32574161 |
|
NCBI chr11:30,204,981...30,204,982
|
|
Q
|
GWAS1476422_H
|
polycystic ovary syndrome QTL GWAS1476422 (human)
|
|
IAGP
|
rs7666129
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:25574032 |
|
NCBI chr 4:188,576,910...188,576,911
|
|
Q
|
GWAS1476423_H
|
polycystic ovary syndrome QTL GWAS1476423 (human)
|
|
IAGP
|
rs10505648
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:25574032 |
|
NCBI chr 8:136,144,207...136,144,208
|
|
Q
|
GWAS1476424_H
|
polycystic ovary syndrome QTL GWAS1476424 (human)
|
|
IAGP
|
rs500492
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:25574032 |
|
NCBI chr16:1,000,877...1,000,878
|
|
Q
|
GWAS1482452_H
|
polycystic ovary syndrome QTL GWAS1482452 (human)
|
|
IAGP
|
rs804279
| 8.0E-10 |
|
|
GWAS_CATALOG |
PMID:26284813 |
|
NCBI chr 8:11,766,380...11,766,381
|
|
Q
|
GWAS1482453_H
|
polycystic ovary syndrome QTL GWAS1482453 (human)
|
|
IAGP
|
rs11031006
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:26284813 |
|
NCBI chr11:30,204,981...30,204,982
|
|
Q
|
GWAS1482660_H
|
polycystic ovary syndrome QTL GWAS1482660 (human)
|
|
IAGP
|
rs1355471
| 8.0E-8 |
|
|
GWAS_CATALOG |
PMID:26284813 |
|
NCBI chr12:28,568,792...28,568,793
|
|
Q
|
GWAS1497889_H
|
polycystic ovary syndrome QTL GWAS1497889 (human)
|
|
IAGP
|
rs11031006
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:26416764 |
|
NCBI chr11:30,204,981...30,204,982
|
|
Q
|
GWAS1497890_H
|
polycystic ovary syndrome QTL GWAS1497890 (human)
|
|
IAGP
|
rs13164856
| 4.0E-9 |
|
|
GWAS_CATALOG |
PMID:26416764 |
|
NCBI chr 5:132,477,512...132,477,513
|
|
Q
|
GWAS1497891_H
|
polycystic ovary syndrome QTL GWAS1497891 (human)
|
|
IAGP
|
rs7218361
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:26416764 |
|
NCBI chr17:39,569,151...39,569,152
|
|
Q
|
GWAS1497892_H
|
polycystic ovary syndrome QTL GWAS1497892 (human)
|
|
IAGP
|
rs10760321
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:26416764 |
|
NCBI chr 9:124,101,917...124,101,918
|
|
Q
|
GWAS1521225_H
|
polycystic ovary syndrome, type 2 diabetes mellitus QTL GWAS1521225 (human)
|
|
IAGP
|
rs1509097
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
NCBI chr 2:164,881,421...164,881,422
|
|
Q
|
GWAS1521226_H
|
polycystic ovary syndrome, type 2 diabetes mellitus QTL GWAS1521226 (human)
|
|
IAGP
|
rs2238689
| 1.0E-23 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
NCBI chr19:45,675,403...45,675,404
|
|
Q
|
GWAS1521228_H
|
HbA1c measurement, polycystic ovary syndrome QTL GWAS1521228 (human)
|
|
IAGP
|
rs1265564
| 3.0E-13 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
NCBI chr12:111,270,654...111,270,655
|
|
Q
|
GWAS1521230_H
|
HbA1c measurement, polycystic ovary syndrome QTL GWAS1521230 (human)
|
|
IAGP
|
rs4731113
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
NCBI chr 7:123,643,895...123,643,896
|
|
Q
|
GWAS1536581_H
|
polycystic ovary syndrome QTL GWAS1536581 (human)
|
|
IAGP
|
rs11031002
| 9.0E-9 |
|
|
GWAS_CATALOG |
PMID:34791234 |
|
NCBI chr11:30,193,714...30,193,715
|
|
Q
|
GWAS1565771_H
|
polycystic ovary syndrome QTL GWAS1565771 (human)
|
|
IAGP
|
rs13164856
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr 5:132,477,512...132,477,513
|
|
Q
|
GWAS1565772_H
|
polycystic ovary syndrome QTL GWAS1565772 (human)
|
|
IAGP
|
rs804279
| 4.0E-12 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr 8:11,766,380...11,766,381
|
|
Q
|
GWAS1565773_H
|
polycystic ovary syndrome QTL GWAS1565773 (human)
|
|
IAGP
|
rs11031005
| 9.0E-13 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr11:30,204,809...30,204,810
|
|
Q
|
GWAS1565774_H
|
polycystic ovary syndrome QTL GWAS1565774 (human)
|
|
IAGP
|
rs8043701
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:30566500 |
|
NCBI chr16:52,341,865...52,341,866
|
|
Q
|
GWAS1573028_H
|
polycystic ovary syndrome QTL GWAS1573028 (human)
|
|
IAGP
|
rs1159315
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:30343302 |
|
NCBI chr 4:47,001,059...47,001,060
|
|
Q
|
GWAS1739363_H
|
polycystic ovary syndrome, blood insulin amount QTL GWAS1739363 (human)
|
|
IAGP
|
rs745379
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
|
|
Q
|
GWAS1739364_H
|
polycystic ovary syndrome, blood insulin amount QTL GWAS1739364 (human)
|
|
IAGP
|
rs3813583
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
|
|
Q
|
GWAS1739365_H
|
polycystic ovary syndrome, blood insulin amount QTL GWAS1739365 (human)
|
|
IAGP
|
rs4135247
| 6.0E-9 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
|
|
Q
|
GWAS1757844_H
|
cholesteryl esters:total lipids ratio, blood VLDL cholesterol amount QTL GWAS1757844 (human)
|
|
IAGP
|
rs2238689
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
|
|
Q
|
GWAS1814146_H
|
blood glucose amount, polycystic ovary syndrome QTL GWAS1814146 (human)
|
|
IAGP
|
rs72753599
| 2.0E-12 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
|
|
Q
|
GWAS1814147_H
|
blood glucose amount, polycystic ovary syndrome QTL GWAS1814147 (human)
|
|
IAGP
|
rs9844212
| 4.0E-13 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
|
|
Q
|
GWAS1814148_H
|
blood glucose amount, polycystic ovary syndrome QTL GWAS1814148 (human)
|
|
IAGP
|
rs6485690
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:35771237 |
|
|
|
Q
|
GWAS1814621_H
|
polycystic ovary syndrome QTL GWAS1814621 (human)
|
|
IAGP
|
rs72664661
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814663_H
|
polycystic ovary syndrome QTL GWAS1814663 (human)
|
|
IAGP
|
rs71420994
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814664_H
|
polycystic ovary syndrome QTL GWAS1814664 (human)
|
|
IAGP
|
rs12487145
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814665_H
|
polycystic ovary syndrome QTL GWAS1814665 (human)
|
|
IAGP
|
rs73188538
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814666_H
|
polycystic ovary syndrome QTL GWAS1814666 (human)
|
|
IAGP
|
rs113705770
| 7.0E-7 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814667_H
|
polycystic ovary syndrome QTL GWAS1814667 (human)
|
|
IAGP
|
rs4691154
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814668_H
|
polycystic ovary syndrome QTL GWAS1814668 (human)
|
|
IAGP
|
rs2070729
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814669_H
|
polycystic ovary syndrome QTL GWAS1814669 (human)
|
|
IAGP
|
rs13190662
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814670_H
|
polycystic ovary syndrome QTL GWAS1814670 (human)
|
|
IAGP
|
rs17719900
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814671_H
|
polycystic ovary syndrome QTL GWAS1814671 (human)
|
|
IAGP
|
rs112400145
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814672_H
|
polycystic ovary syndrome QTL GWAS1814672 (human)
|
|
IAGP
|
rs17807624
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814673_H
|
polycystic ovary syndrome QTL GWAS1814673 (human)
|
|
IAGP
|
rs12000707
| 2.0E-12 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814674_H
|
polycystic ovary syndrome QTL GWAS1814674 (human)
|
|
IAGP
|
rs111520626
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814675_H
|
polycystic ovary syndrome QTL GWAS1814675 (human)
|
|
IAGP
|
rs1148005
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814676_H
|
polycystic ovary syndrome QTL GWAS1814676 (human)
|
|
IAGP
|
rs9550239
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814677_H
|
polycystic ovary syndrome QTL GWAS1814677 (human)
|
|
IAGP
|
rs77889472
| 6.0E-7 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814732_H
|
polycystic ovary syndrome QTL GWAS1814732 (human)
|
|
IAGP
|
rs62095018
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814733_H
|
polycystic ovary syndrome QTL GWAS1814733 (human)
|
|
IAGP
|
rs2228260
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814734_H
|
polycystic ovary syndrome QTL GWAS1814734 (human)
|
|
IAGP
|
rs11031006
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814735_H
|
polycystic ovary syndrome QTL GWAS1814735 (human)
|
|
IAGP
|
rs543527054
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814736_H
|
polycystic ovary syndrome QTL GWAS1814736 (human)
|
|
IAGP
|
rs112867071
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814737_H
|
polycystic ovary syndrome QTL GWAS1814737 (human)
|
|
IAGP
|
rs3902025
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814738_H
|
polycystic ovary syndrome QTL GWAS1814738 (human)
|
|
IAGP
|
rs117460293
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814739_H
|
polycystic ovary syndrome QTL GWAS1814739 (human)
|
|
IAGP
|
rs9533805
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814740_H
|
polycystic ovary syndrome QTL GWAS1814740 (human)
|
|
IAGP
|
rs12965518
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814741_H
|
polycystic ovary syndrome QTL GWAS1814741 (human)
|
|
IAGP
|
rs813684
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814742_H
|
polycystic ovary syndrome QTL GWAS1814742 (human)
|
|
IAGP
|
rs11453664
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814743_H
|
polycystic ovary syndrome QTL GWAS1814743 (human)
|
|
IAGP
|
rs12992690
| 6.0E-7 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814744_H
|
polycystic ovary syndrome QTL GWAS1814744 (human)
|
|
IAGP
|
rs906867
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814745_H
|
polycystic ovary syndrome QTL GWAS1814745 (human)
|
|
IAGP
|
rs9613552
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814778_H
|
polycystic ovary syndrome QTL GWAS1814778 (human)
|
|
IAGP
|
rs4821825
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814779_H
|
polycystic ovary syndrome QTL GWAS1814779 (human)
|
|
IAGP
|
rs537314545
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814780_H
|
polycystic ovary syndrome QTL GWAS1814780 (human)
|
|
IAGP
|
rs77851804
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814781_H
|
polycystic ovary syndrome QTL GWAS1814781 (human)
|
|
IAGP
|
rs77388455
| 9.0E-7 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814782_H
|
polycystic ovary syndrome QTL GWAS1814782 (human)
|
|
IAGP
|
rs56294845
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814783_H
|
polycystic ovary syndrome QTL GWAS1814783 (human)
|
|
IAGP
|
rs3729853
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814784_H
|
polycystic ovary syndrome QTL GWAS1814784 (human)
|
|
IAGP
|
rs569675099
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1814785_H
|
polycystic ovary syndrome QTL GWAS1814785 (human)
|
|
IAGP
|
rs2382453
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:38408933 |
|
|
|
Q
|
GWAS1822456_H
|
polycystic ovary syndrome QTL GWAS1822456 (human)
|
|
IAGP
|
rs7563201
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
Q
|
GWAS1822457_H
|
polycystic ovary syndrome QTL GWAS1822457 (human)
|
|
IAGP
|
rs7578655
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
Q
|
GWAS1822458_H
|
polycystic ovary syndrome QTL GWAS1822458 (human)
|
|
IAGP
|
rs13427822
| 9.0E-10 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
Q
|
GWAS1822496_H
|
polycystic ovary syndrome QTL GWAS1822496 (human)
|
|
IAGP
|
rs4705862
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
Q
|
GWAS1822497_H
|
polycystic ovary syndrome QTL GWAS1822497 (human)
|
|
IAGP
|
rs3729853
| 1.0E-13 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
Q
|
GWAS1822498_H
|
polycystic ovary syndrome QTL GWAS1822498 (human)
|
|
IAGP
|
rs7030193
| 3.0E-22 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
Q
|
GWAS1822499_H
|
polycystic ovary syndrome QTL GWAS1822499 (human)
|
|
IAGP
|
rs11031002
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
Q
|
GWAS1822500_H
|
polycystic ovary syndrome QTL GWAS1822500 (human)
|
|
IAGP
|
rs1672716
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
Q
|
GWAS1822501_H
|
polycystic ovary syndrome QTL GWAS1822501 (human)
|
|
IAGP
|
rs1824982
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
Q
|
GWAS1822502_H
|
polycystic ovary syndrome QTL GWAS1822502 (human)
|
|
IAGP
|
rs17879961
| 3.0E-20 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
Q
|
GWAS1822503_H
|
polycystic ovary syndrome QTL GWAS1822503 (human)
|
|
IAGP
|
rs562567873
| 5.0E-9 |
|
|
GWAS_CATALOG |
PMID:40069456 |
|
|
|
Q
|
GWAS568970_H
|
polycystic ovary syndrome QTL GWAS568970 (human)
|
|
IAGP
|
rs17023134
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:32574161 |
|
NCBI chr 4:95,183,520...95,183,521
|
|
Q
|
GWAS588007_H
|
polycystic ovary syndrome QTL GWAS588007 (human)
|
|
IAGP
|
rs113168128
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:32289280 |
|
NCBI chr 2:211,427,047...211,427,048
|
|
Q
|
GWAS588008_H
|
polycystic ovary syndrome QTL GWAS588008 (human)
|
|
IAGP
|
rs144248326
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:32289280 |
|
NCBI chr 3:149,602,086...149,602,087
|
|
Q
|
GWAS624860_H
|
polycystic ovary syndrome QTL GWAS624860 (human)
|
|
IAGP
|
rs13405728
| 8.0E-21 |
|
|
GWAS_CATALOG |
PMID:21151128 |
|
NCBI chr 2:48,751,020...48,751,021
|
|
Q
|
GWAS638858_H
|
polycystic ovary syndrome QTL GWAS638858 (human)
|
|
IAGP
|
rs13405728
| 4.0E-9 |
|
|
GWAS_CATALOG |
PMID:22885925 |
|
NCBI chr 2:48,751,020...48,751,021
|
|
Q
|
GWAS674066_H
|
polycystic ovary syndrome QTL GWAS674066 (human)
|
|
IAGP
|
rs13429458
| 2.0E-23 |
|
|
GWAS_CATALOG |
PMID:21151128 |
|
NCBI chr 2:43,411,699...43,411,700
|
|
Q
|
GWAS674067_H
|
polycystic ovary syndrome QTL GWAS674067 (human)
|
|
IAGP
|
rs10818854
| 9.0E-18 |
|
|
GWAS_CATALOG |
PMID:21151128 |
|
NCBI chr 9:123,684,499...123,684,500
|
|
Q
|
GWAS674068_H
|
polycystic ovary syndrome QTL GWAS674068 (human)
|
|
IAGP
|
rs2479106
| 8.0E-19 |
|
|
GWAS_CATALOG |
PMID:21151128 |
|
NCBI chr 9:123,762,933...123,762,934
|
|
Q
|
GWAS674070_H
|
polycystic ovary syndrome QTL GWAS674070 (human)
|
|
IAGP
|
rs12478601
| 3.0E-23 |
|
|
GWAS_CATALOG |
PMID:21151128 |
|
NCBI chr 2:43,494,369...43,494,370
|
|
Q
|
GWAS692014_H
|
polycystic ovary syndrome QTL GWAS692014 (human)
|
|
IAGP
|
rs13429458
| 4.0E-13 |
|
|
GWAS_CATALOG |
PMID:22885925 |
|
NCBI chr 2:43,411,699...43,411,700
|
|
Q
|
GWAS692015_H
|
polycystic ovary syndrome QTL GWAS692015 (human)
|
|
IAGP
|
rs2479106
| 5.0E-10 |
|
|
GWAS_CATALOG |
PMID:22885925 |
|
NCBI chr 9:123,762,933...123,762,934
|
|
Q
|
GWAS692018_H
|
polycystic ovary syndrome QTL GWAS692018 (human)
|
|
IAGP
|
rs3802457
| 5.0E-14 |
|
|
GWAS_CATALOG |
PMID:22885925 |
|
NCBI chr 9:94,979,054...94,979,055
|
|
Q
|
GWAS692019_H
|
polycystic ovary syndrome QTL GWAS692019 (human)
|
|
IAGP
|
rs1894116
| 1.0E-22 |
|
|
GWAS_CATALOG |
PMID:22885925 |
|
NCBI chr11:102,199,908...102,199,909
|
|
Q
|
GWAS692021_H
|
polycystic ovary syndrome QTL GWAS692021 (human)
|
|
IAGP
|
rs2272046
| 2.0E-21 |
|
|
GWAS_CATALOG |
PMID:22885925 |
|
NCBI chr12:65,830,681...65,830,682
|
|
Q
|
GWAS692023_H
|
polycystic ovary syndrome QTL GWAS692023 (human)
|
|
IAGP
|
rs2059807
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:22885925 |
|
NCBI chr19:7,166,098...7,166,099
|
|
Q
|
GWAS704951_H
|
polycystic ovary syndrome QTL GWAS704951 (human)
|
|
IAGP
|
rs7735176
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:32574161 |
|
NCBI chr 5:24,728,347...24,728,348
|
|
Q
|
GWAS704952_H
|
polycystic ovary syndrome QTL GWAS704952 (human)
|
|
IAGP
|
rs55762028
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:32574161 |
|
NCBI chr 2:163,325,912...163,325,913
|
|
Q
|
GWAS773889_H
|
polycystic ovary syndrome QTL GWAS773889 (human)
|
|
IAGP
|
rs2268361
| 1.0E-12 |
|
|
GWAS_CATALOG |
PMID:22885925 |
|
NCBI chr 2:48,974,473...48,974,474
|
|
|
Q
|
GWAS1163549_H
|
primary ovarian insufficiency QTL GWAS1163549 (human)
|
|
IAGP
|
rs10793451
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:29432556 |
|
NCBI chr10:43,608,447...43,608,448
|
|
Q
|
GWAS1163550_H
|
primary ovarian insufficiency QTL GWAS1163550 (human)
|
|
IAGP
|
rs6759058
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:29432556 |
|
NCBI chr 2:45,773,347...45,773,348
|
|
Q
|
GWAS1163551_H
|
primary ovarian insufficiency QTL GWAS1163551 (human)
|
|
IAGP
|
rs10058075
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:29432556 |
|
NCBI chr 5:39,416,192...39,416,193
|
|
Q
|
GWAS1163587_H
|
primary ovarian insufficiency QTL GWAS1163587 (human)
|
|
IAGP
|
rs3966085
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:29432556 |
|
NCBI chr 4:68,964,824...68,964,825
|
|
Q
|
GWAS1506889_H
|
primary ovarian insufficiency QTL GWAS1506889 (human)
|
|
IAGP
|
rs4323056
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:29432556 |
|
NCBI chr 4:155,136,200...155,136,201
|
|
Q
|
GWAS1506890_H
|
primary ovarian insufficiency QTL GWAS1506890 (human)
|
|
IAGP
|
rs2880418
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:29432556 |
|
NCBI chr 4:155,148,727...155,148,728
|
|
Q
|
GWAS1506891_H
|
primary ovarian insufficiency QTL GWAS1506891 (human)
|
|
IAGP
|
rs4402990
| 8.0E-6 |
|
|
GWAS_CATALOG |
PMID:29432556 |
|
NCBI chr 4:155,187,781...155,187,782
|
|
Q
|
GWAS1506892_H
|
primary ovarian insufficiency QTL GWAS1506892 (human)
|
|
IAGP
|
rs9999820
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:29432556 |
|
NCBI chr 4:155,197,173...155,197,174
|
|
Q
|
GWAS697049_H
|
primary ovarian insufficiency QTL GWAS697049 (human)
|
|
IAGP
|
rs3847153
| 9.0E-8 |
|
|
GWAS_CATALOG |
PMID:21989058 |
|
NCBI chr 8:100,800,928...100,800,929
|
|
|
Q
|
GWAS1164442_H
|
Testicular Germ Cell Tumor QTL GWAS1164442 (human)
|
|
IAGP
|
rs7010162
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr 8:70,064,270...70,064,271
|
|
Q
|
GWAS1202175_H
|
testicular carcinoma QTL GWAS1202175 (human)
|
|
IAGP
|
rs186464019
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr11:20,885,094...20,885,095
|
|
Q
|
GWAS1202176_H
|
testicular carcinoma QTL GWAS1202176 (human)
|
|
IAGP
|
rs1907702
| 6.0E-24 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr12:88,561,692...88,561,693
|
|
Q
|
GWAS1202177_H
|
testicular carcinoma QTL GWAS1202177 (human)
|
|
IAGP
|
rs61823671
| 7.0E-7 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr 1:202,092,280...202,092,281
|
|
Q
|
GWAS1202178_H
|
testicular carcinoma QTL GWAS1202178 (human)
|
|
IAGP
|
rs111581773
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr 1:17,770,950...17,770,951
|
|
Q
|
GWAS1202179_H
|
testicular carcinoma QTL GWAS1202179 (human)
|
|
IAGP
|
rs7863616
| 1.0E-14 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr 9:861,220...861,221
|
|
Q
|
GWAS1202180_H
|
testicular carcinoma QTL GWAS1202180 (human)
|
|
IAGP
|
rs9862599
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr 3:105,145,487...105,145,488
|
|
Q
|
GWAS1202181_H
|
testicular carcinoma QTL GWAS1202181 (human)
|
|
IAGP
|
rs10851590
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr15:55,697,741...55,697,742
|
|
Q
|
GWAS1202182_H
|
testicular carcinoma QTL GWAS1202182 (human)
|
|
IAGP
|
rs7659556
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr 4:103,244,962...103,244,963
|
|
Q
|
GWAS1469869_H
|
testicular carcinoma QTL GWAS1469869 (human)
|
|
IAGP
|
rs8046148
| 4.0E-9 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr16:50,109,033...50,109,034
|
|
Q
|
GWAS1469870_H
|
testicular carcinoma QTL GWAS1469870 (human)
|
|
IAGP
|
rs9905704
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr17:58,555,182...58,555,183
|
|
Q
|
GWAS1469871_H
|
testicular carcinoma QTL GWAS1469871 (human)
|
|
IAGP
|
rs3790672
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr 1:165,904,155...165,904,156
|
|
Q
|
GWAS1469872_H
|
testicular carcinoma QTL GWAS1469872 (human)
|
|
IAGP
|
rs2839186
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr21:46,270,154...46,270,155
|
|
Q
|
GWAS1469873_H
|
testicular carcinoma QTL GWAS1469873 (human)
|
|
IAGP
|
rs210138
| 2.0E-24 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr 6:33,574,761...33,574,762
|
|
Q
|
GWAS1471714_H
|
testicular carcinoma QTL GWAS1471714 (human)
|
|
IAGP
|
rs210138
| 1.0E-13 |
|
|
GWAS_CATALOG |
PMID:19483681 |
|
NCBI chr 6:33,574,761...33,574,762
|
|
Q
|
GWAS1471991_H
|
testicular carcinoma QTL GWAS1471991 (human)
|
|
IAGP
|
rs2736100
| 8.0E-15 |
|
|
GWAS_CATALOG |
PMID:20543847 |
|
NCBI chr 5:1,286,401...1,286,402
|
|
Q
|
GWAS1475088_H
|
testicular carcinoma QTL GWAS1475088 (human)
|
|
IAGP
|
rs9905704
| 4.0E-13 |
|
|
GWAS_CATALOG |
PMID:23666239 |
|
NCBI chr17:58,555,182...58,555,183
|
|
Q
|
GWAS1475089_H
|
testicular carcinoma QTL GWAS1475089 (human)
|
|
IAGP
|
rs8046148
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:23666239 |
|
NCBI chr16:50,109,033...50,109,034
|
|
Q
|
GWAS1475090_H
|
testicular carcinoma QTL GWAS1475090 (human)
|
|
IAGP
|
rs210138
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:23666239 |
|
NCBI chr 6:33,574,761...33,574,762
|
|
Q
|
GWAS1571468_H
|
testicular carcinoma QTL GWAS1571468 (human)
|
|
IAGP
|
rs56016578
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr21:36,669,677...36,669,678
|
|
Q
|
GWAS1571469_H
|
testicular carcinoma QTL GWAS1571469 (human)
|
|
IAGP
|
rs185424124
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr 1:68,792,011...68,792,012
|
|
Q
|
GWAS1571470_H
|
testicular carcinoma QTL GWAS1571470 (human)
|
|
IAGP
|
rs80348946
| 8.0E-7 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr 2:22,149,507...22,149,508
|
|
Q
|
GWAS1571471_H
|
testicular carcinoma QTL GWAS1571471 (human)
|
|
IAGP
|
rs36115365
| 2.0E-13 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr 5:1,313,127...1,313,128
|
|
Q
|
GWAS1571472_H
|
testicular carcinoma QTL GWAS1571472 (human)
|
|
IAGP
|
rs61193264
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr19:23,651,293...23,651,294
|
|
Q
|
GWAS1571473_H
|
testicular carcinoma QTL GWAS1571473 (human)
|
|
IAGP
|
rs11104702
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:32887889 |
|
NCBI chr12:87,985,743...87,985,744
|
|
Q
|
GWAS561506_H
|
testicular carcinoma QTL GWAS561506 (human)
|
|
IAGP
|
rs2072499
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr 1:156,199,819...156,199,820
|
|
Q
|
GWAS561507_H
|
testicular carcinoma QTL GWAS561507 (human)
|
|
IAGP
|
rs4635969
| 5.0E-24 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr 5:1,308,437...1,308,438
|
|
Q
|
GWAS561512_H
|
testicular carcinoma QTL GWAS561512 (human)
|
|
IAGP
|
rs4624820
| 3.0E-31 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr 5:142,302,223...142,302,224
|
|
Q
|
GWAS564844_H
|
testicular carcinoma QTL GWAS564844 (human)
|
|
IAGP
|
rs4624820
| 1.0E-14 |
|
|
GWAS_CATALOG |
PMID:20543847 |
|
NCBI chr 5:142,302,223...142,302,224
|
|
Q
|
GWAS564905_H
|
testicular carcinoma QTL GWAS564905 (human)
|
|
IAGP
|
rs4635969
| 1.0E-23 |
|
|
GWAS_CATALOG |
PMID:20543847 |
|
NCBI chr 5:1,308,437...1,308,438
|
|
Q
|
GWAS572868_H
|
testicular carcinoma QTL GWAS572868 (human)
|
|
IAGP
|
rs4624820
| 3.0E-13 |
|
|
GWAS_CATALOG |
PMID:19483681 |
|
NCBI chr 5:142,302,223...142,302,224
|
|
Q
|
GWAS640350_H
|
testicular carcinoma QTL GWAS640350 (human)
|
|
IAGP
|
rs4624820
| 8.0E-10 |
|
|
GWAS_CATALOG |
PMID:23666239 |
|
NCBI chr 5:142,302,223...142,302,224
|
|
Q
|
GWAS668651_H
|
testicular carcinoma QTL GWAS668651 (human)
|
|
IAGP
|
rs4474514
| 6.0E-15 |
|
|
GWAS_CATALOG |
PMID:19483682 |
|
NCBI chr12:88,560,182...88,560,183
|
|
Q
|
GWAS674960_H
|
testicular carcinoma QTL GWAS674960 (human)
|
|
IAGP
|
rs995030
| 1.0E-31 |
|
|
GWAS_CATALOG |
PMID:19483681 |
|
NCBI chr12:88,496,894...88,496,895
|
|
Q
|
GWAS674961_H
|
testicular carcinoma QTL GWAS674961 (human)
|
|
IAGP
|
rs4699052
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:19483681 |
|
NCBI chr 4:103,216,633...103,216,634
|
|
Q
|
GWAS674964_H
|
testicular carcinoma QTL GWAS674964 (human)
|
|
IAGP
|
rs995030
| 3.0E-30 |
|
|
GWAS_CATALOG |
PMID:19483681 |
|
NCBI chr12:88,496,894...88,496,895
|
|
Q
|
GWAS674965_H
|
testicular carcinoma QTL GWAS674965 (human)
|
|
IAGP
|
rs4657482
| 2.0E-6 |
|
|
GWAS_CATALOG |
PMID:19483681 |
|
NCBI chr 1:165,862,412...165,862,413
|
|
Q
|
GWAS676066_H
|
testicular carcinoma QTL GWAS676066 (human)
|
|
IAGP
|
rs3782181
| 2.0E-26 |
|
|
GWAS_CATALOG |
PMID:20543847 |
|
NCBI chr12:88,559,784...88,559,785
|
|
Q
|
GWAS676069_H
|
testicular carcinoma QTL GWAS676069 (human)
|
|
IAGP
|
rs755383
| 1.0E-23 |
|
|
GWAS_CATALOG |
PMID:20543847 |
|
NCBI chr 9:863,635...863,636
|
|
Q
|
GWAS676070_H
|
testicular carcinoma QTL GWAS676070 (human)
|
|
IAGP
|
rs2900333
| 6.0E-10 |
|
|
GWAS_CATALOG |
PMID:20543847 |
|
NCBI chr12:14,500,933...14,500,934
|
|
Q
|
GWAS677393_H
|
testicular carcinoma QTL GWAS677393 (human)
|
|
IAGP
|
rs10510452
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr 3:16,583,541...16,583,542
|
|
Q
|
GWAS677394_H
|
testicular carcinoma QTL GWAS677394 (human)
|
|
IAGP
|
rs2720460
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr 4:103,133,529...103,133,530
|
|
Q
|
GWAS677395_H
|
testicular carcinoma QTL GWAS677395 (human)
|
|
IAGP
|
rs3805663
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr 5:135,030,510...135,030,511
|
|
Q
|
GWAS677403_H
|
testicular carcinoma QTL GWAS677403 (human)
|
|
IAGP
|
rs755383
| 2.0E-26 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr 9:863,635...863,636
|
|
Q
|
GWAS677404_H
|
testicular carcinoma QTL GWAS677404 (human)
|
|
IAGP
|
rs2900333
| 1.0E-13 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr12:14,500,933...14,500,934
|
|
Q
|
GWAS677405_H
|
testicular carcinoma QTL GWAS677405 (human)
|
|
IAGP
|
rs995030
| 2.0E-50 |
|
|
GWAS_CATALOG |
PMID:23666240 |
|
NCBI chr12:88,496,894...88,496,895
|
|
Q
|
GWAS700458_H
|
testicular carcinoma QTL GWAS700458 (human)
|
|
IAGP
|
rs4888262
| 5.0E-12 |
|
|
GWAS_CATALOG |
PMID:23666239 |
|
NCBI chr16:74,636,560...74,636,561
|
|
Q
|
GWAS700459_H
|
testicular carcinoma QTL GWAS700459 (human)
|
|
IAGP
|
rs17021463
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:23666239 |
|
NCBI chr 4:94,303,661...94,303,662
|
|
Q
|
GWAS700461_H
|
testicular carcinoma QTL GWAS700461 (human)
|
|
IAGP
|
rs9951026
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:23666239 |
|
NCBI chr18:49,583,323...49,583,324
|
|
Q
|
GWAS700463_H
|
testicular carcinoma QTL GWAS700463 (human)
|
|
IAGP
|
rs4657482
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:23666239 |
|
NCBI chr 1:165,862,412...165,862,413
|
|
Q
|
GWAS700471_H
|
testicular carcinoma QTL GWAS700471 (human)
|
|
IAGP
|
rs995030
| 3.0E-13 |
|
|
GWAS_CATALOG |
PMID:23666239 |
|
NCBI chr12:88,496,894...88,496,895
|
|
Q
|
GWAS700472_H
|
testicular carcinoma QTL GWAS700472 (human)
|
|
IAGP
|
rs755383
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:23666239 |
|
NCBI chr 9:863,635...863,636
|
|
Q
|
GWAS701081_H
|
testicular carcinoma QTL GWAS701081 (human)
|
|
IAGP
|
rs755383
| 9.0E-10 |
|
|
GWAS_CATALOG |
PMID:21551455 |
|
NCBI chr 9:863,635...863,636
|
|
Q
|
GWAS701082_H
|
testicular carcinoma QTL GWAS701082 (human)
|
|
IAGP
|
rs7040024
| 1.0E-11 |
|
|
GWAS_CATALOG |
PMID:21551455 |
|
NCBI chr 9:845,516...845,517
|
|
Q
|
GWAS794976_H
|
testicular carcinoma QTL GWAS794976 (human)
|
|
IAGP
|
rs12699477
| 6.0E-9 |
|
|
GWAS_CATALOG |
PMID:23666239 |
|
NCBI chr 7:1,929,317...1,929,318
|
|
|
Q
|
GWAS1137840_H
|
serum metabolite measurement QTL GWAS1137840 (human)
|
|
IAGP
|
rs1260326
| 5.0E-12 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr 2:27,508,073...27,508,074
|
|
Q
|
GWAS1636885_H
|
testicular disease QTL GWAS1636885 (human)
|
|
IAGP
|
rs1260326
| 9.0E-15 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr 2:27,508,073...27,508,074
|
|
Q
|
GWAS1636887_H
|
testicular disease QTL GWAS1636887 (human)
|
|
IAGP
|
rs1260326
| 4.0E-14 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr 2:27,508,073...27,508,074
|
|
Q
|
GWAS1648645_H
|
testicular disease QTL GWAS1648645 (human)
|
|
IAGP
|
rs4849183
| 8.0E-27 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr 2:113,234,797...113,234,798
|
|
Q
|
GWAS1666313_H
|
testicular disease QTL GWAS1666313 (human)
|
|
IAGP
|
rs1260326
| 3.0E-12 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr 2:27,508,073...27,508,074
|
|
Q
|
GWAS1666314_H
|
testicular disease QTL GWAS1666314 (human)
|
|
IAGP
|
rs9414801
| 2.0E-20 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr10:63,389,329...63,389,330
|
|
Q
|
GWAS1666398_H
|
testicular disease QTL GWAS1666398 (human)
|
|
IAGP
|
rs11651783
| 2.0E-36 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr17:7,544,593...7,544,594
|
|
Q
|
GWAS1666399_H
|
testicular disease QTL GWAS1666399 (human)
|
|
IAGP
|
rs10995477
| 5.0E-20 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr10:63,250,912...63,250,913
|
|
Q
|
GWAS1666481_H
|
testicular disease QTL GWAS1666481 (human)
|
|
IAGP
|
rs77294902
| 7.0E-37 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr17:7,548,761...7,548,762
|
|
Q
|
GWAS1671599_H
|
testicular disease QTL GWAS1671599 (human)
|
|
IAGP
|
rs2015769
| 8.0E-26 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr 2:113,200,060...113,200,061
|
|
Q
|
GWAS1671600_H
|
testicular disease QTL GWAS1671600 (human)
|
|
IAGP
|
rs6718024
| 9.0E-22 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr 2:120,367,311...120,367,312
|
|
Q
|
GWAS1672151_H
|
testicular disease QTL GWAS1672151 (human)
|
|
IAGP
|
rs56157317
| 4.0E-11 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
NCBI chr 7:155,844,892...155,844,893
|
|
Q
|
GWAS1694131_H
|
testicular disease QTL GWAS1694131 (human)
|
|
IAGP
|
rs56196860
| 7.0E-16 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
|
|
Q
|
GWAS1694160_H
|
testicular disease QTL GWAS1694160 (human)
|
|
IAGP
|
rs56196860
| 6.0E-16 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
|
|
Q
|
GWAS1696081_H
|
testicular disease QTL GWAS1696081 (human)
|
|
IAGP
|
rs56196860
| 5.0E-18 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
|
|
Q
|
GWAS1696082_H
|
testicular disease QTL GWAS1696082 (human)
|
|
IAGP
|
rs56196860
| 2.0E-17 |
|
|
GWAS_CATALOG |
PMID:39024449 |
|
|
|
|
Q
|
GWAS1164415_H
|
Testicular Germ Cell Tumor QTL GWAS1164415 (human)
|
|
IAGP
|
rs2072499
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 1:156,199,819...156,199,820
|
|
Q
|
GWAS1164416_H
|
Testicular Germ Cell Tumor QTL GWAS1164416 (human)
|
|
IAGP
|
rs7581030
| 2.0E-11 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 2:71,345,325...71,345,326
|
|
Q
|
GWAS1164417_H
|
Testicular Germ Cell Tumor QTL GWAS1164417 (human)
|
|
IAGP
|
rs10510452
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 3:16,583,541...16,583,542
|
|
Q
|
GWAS1164418_H
|
Testicular Germ Cell Tumor QTL GWAS1164418 (human)
|
|
IAGP
|
rs11705932
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 3:142,100,008...142,100,009
|
|
Q
|
GWAS1164419_H
|
Testicular Germ Cell Tumor QTL GWAS1164419 (human)
|
|
IAGP
|
rs1510272
| 2.0E-12 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 3:156,582,935...156,582,936
|
|
Q
|
GWAS1164420_H
|
Testicular Germ Cell Tumor QTL GWAS1164420 (human)
|
|
IAGP
|
rs6821144
| 2.0E-11 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 4:75,595,467...75,595,468
|
|
Q
|
GWAS1164421_H
|
Testicular Germ Cell Tumor QTL GWAS1164421 (human)
|
|
IAGP
|
rs17021463
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 4:94,303,661...94,303,662
|
|
Q
|
GWAS1164422_H
|
Testicular Germ Cell Tumor QTL GWAS1164422 (human)
|
|
IAGP
|
rs2720460
| 7.0E-20 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 4:103,133,529...103,133,530
|
|
Q
|
GWAS1164423_H
|
Testicular Germ Cell Tumor QTL GWAS1164423 (human)
|
|
IAGP
|
rs4862848
| 2.0E-12 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 4:188,000,286...188,000,287
|
|
Q
|
GWAS1164424_H
|
Testicular Germ Cell Tumor QTL GWAS1164424 (human)
|
|
IAGP
|
rs4624820
| 3.0E-57 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 5:142,302,223...142,302,224
|
|
Q
|
GWAS1164425_H
|
Testicular Germ Cell Tumor QTL GWAS1164425 (human)
|
|
IAGP
|
rs11155671
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 6:149,650,996...149,650,997
|
|
Q
|
GWAS1164440_H
|
Testicular Germ Cell Tumor QTL GWAS1164440 (human)
|
|
IAGP
|
rs12699477
| 6.0E-13 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 7:1,929,317...1,929,318
|
|
Q
|
GWAS1164441_H
|
Testicular Germ Cell Tumor QTL GWAS1164441 (human)
|
|
IAGP
|
rs17153755
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 8:11,753,991...11,753,992
|
|
Q
|
GWAS1164442_H
|
Testicular Germ Cell Tumor QTL GWAS1164442 (human)
|
|
IAGP
|
rs7010162
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 8:70,064,270...70,064,271
|
|
Q
|
GWAS1164443_H
|
Testicular Germ Cell Tumor QTL GWAS1164443 (human)
|
|
IAGP
|
rs7040024
| 2.0E-45 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 9:845,516...845,517
|
|
Q
|
GWAS1164444_H
|
Testicular Germ Cell Tumor QTL GWAS1164444 (human)
|
|
IAGP
|
rs7107174
| 5.0E-6 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr11:78,286,890...78,286,891
|
|
Q
|
GWAS1164445_H
|
Testicular Germ Cell Tumor QTL GWAS1164445 (human)
|
|
IAGP
|
rs648090
| 2.0E-12 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr11:125,201,267...125,201,268
|
|
Q
|
GWAS1164446_H
|
Testicular Germ Cell Tumor QTL GWAS1164446 (human)
|
|
IAGP
|
rs2900333
| 9.0E-13 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr12:14,500,933...14,500,934
|
|
Q
|
GWAS1164447_H
|
Testicular Germ Cell Tumor QTL GWAS1164447 (human)
|
|
IAGP
|
rs4931000
| 2.0E-11 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr12:31,988,561...31,988,562
|
|
Q
|
GWAS1164448_H
|
Testicular Germ Cell Tumor QTL GWAS1164448 (human)
|
|
IAGP
|
rs3782181
| 3E-129 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr12:88,559,784...88,559,785
|
|
Q
|
GWAS1164449_H
|
Testicular Germ Cell Tumor QTL GWAS1164449 (human)
|
|
IAGP
|
rs1009647
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr14:55,413,329...55,413,330
|
|
Q
|
GWAS1164463_H
|
Testicular Germ Cell Tumor QTL GWAS1164463 (human)
|
|
IAGP
|
rs11071896
| 8.0E-13 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr15:66,528,912...66,528,913
|
|
Q
|
GWAS1164464_H
|
Testicular Germ Cell Tumor QTL GWAS1164464 (human)
|
|
IAGP
|
rs56046484
| 5.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr15:85,062,196...85,062,197
|
|
Q
|
GWAS1164465_H
|
Testicular Germ Cell Tumor QTL GWAS1164465 (human)
|
|
IAGP
|
rs7404843
| 8.0E-13 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr16:15,436,851...15,436,852
|
|
Q
|
GWAS1164466_H
|
Testicular Germ Cell Tumor QTL GWAS1164466 (human)
|
|
IAGP
|
rs4888262
| 7.0E-12 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr16:74,636,560...74,636,561
|
|
Q
|
GWAS1164467_H
|
Testicular Germ Cell Tumor QTL GWAS1164467 (human)
|
|
IAGP
|
rs55637647
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr16:88,482,856...88,482,857
|
|
Q
|
GWAS1164468_H
|
Testicular Germ Cell Tumor QTL GWAS1164468 (human)
|
|
IAGP
|
rs7501939
| 3.0E-20 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr17:37,741,165...37,741,166
|
|
Q
|
GWAS1164469_H
|
Testicular Germ Cell Tumor QTL GWAS1164469 (human)
|
|
IAGP
|
rs2195987
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr19:23,966,743...23,966,744
|
|
Q
|
GWAS1164470_H
|
Testicular Germ Cell Tumor QTL GWAS1164470 (human)
|
|
IAGP
|
rs4599029
| 1.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr19:53,781,435...53,781,436
|
|
Q
|
GWAS1164471_H
|
Testicular Germ Cell Tumor QTL GWAS1164471 (human)
|
|
IAGP
|
rs12481572
| 3.0E-12 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr20:52,091,515...52,091,516
|
|
Q
|
GWAS1164472_H
|
Testicular Germ Cell Tumor QTL GWAS1164472 (human)
|
|
IAGP
|
rs739525
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr22:20,978,152...20,978,153
|
|
Q
|
GWAS1164867_H
|
Testicular Germ Cell Tumor QTL GWAS1164867 (human)
|
|
IAGP
|
rs2713206
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 2:121,250,365...121,250,366
|
|
Q
|
GWAS1164868_H
|
Testicular Germ Cell Tumor QTL GWAS1164868 (human)
|
|
IAGP
|
rs6837349
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 4:188,000,201...188,000,202
|
|
Q
|
GWAS1164869_H
|
Testicular Germ Cell Tumor QTL GWAS1164869 (human)
|
|
IAGP
|
rs11769858
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 7:158,708,801...158,708,802
|
|
Q
|
GWAS1164870_H
|
Testicular Germ Cell Tumor QTL GWAS1164870 (human)
|
|
IAGP
|
rs55873183
| 2.0E-23 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 9:878,563...878,564
|
|
Q
|
GWAS1164871_H
|
Testicular Germ Cell Tumor QTL GWAS1164871 (human)
|
|
IAGP
|
rs61408740
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr10:124,586,043...124,586,044
|
|
Q
|
GWAS1164872_H
|
Testicular Germ Cell Tumor QTL GWAS1164872 (human)
|
|
IAGP
|
rs12912292
| 1.0E-11 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr15:55,746,509...55,746,510
|
|
Q
|
GWAS1164873_H
|
Testicular Germ Cell Tumor QTL GWAS1164873 (human)
|
|
IAGP
|
rs73019876
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr19:22,085,047...22,085,048
|
|
Q
|
GWAS1164874_H
|
Testicular Germ Cell Tumor QTL GWAS1164874 (human)
|
|
IAGP
|
rs17336718
| 4.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr X:154,307,767...154,307,768
|
|
Q
|
GWAS1164875_H
|
Testicular Germ Cell Tumor QTL GWAS1164875 (human)
|
|
IAGP
|
rs2072499
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 1:156,199,819...156,199,820
|
|
Q
|
GWAS1164899_H
|
Testicular Germ Cell Tumor QTL GWAS1164899 (human)
|
|
IAGP
|
rs10510452
| 3.0E-10 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 3:16,583,541...16,583,542
|
|
Q
|
GWAS1164900_H
|
Testicular Germ Cell Tumor QTL GWAS1164900 (human)
|
|
IAGP
|
rs1510272
| 7.0E-9 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 3:156,582,935...156,582,936
|
|
Q
|
GWAS1164901_H
|
Testicular Germ Cell Tumor QTL GWAS1164901 (human)
|
|
IAGP
|
rs17021463
| 1.0E-6 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 4:94,303,661...94,303,662
|
|
Q
|
GWAS1164902_H
|
Testicular Germ Cell Tumor QTL GWAS1164902 (human)
|
|
IAGP
|
rs2720460
| 1.0E-16 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 4:103,133,529...103,133,530
|
|
Q
|
GWAS1164903_H
|
Testicular Germ Cell Tumor QTL GWAS1164903 (human)
|
|
IAGP
|
rs4635969
| 3.0E-27 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 5:1,308,437...1,308,438
|
|
Q
|
GWAS1164904_H
|
Testicular Germ Cell Tumor QTL GWAS1164904 (human)
|
|
IAGP
|
rs3805663
| 9.0E-6 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 5:135,030,510...135,030,511
|
|
Q
|
GWAS1164905_H
|
Testicular Germ Cell Tumor QTL GWAS1164905 (human)
|
|
IAGP
|
rs4624820
| 3.0E-46 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 5:142,302,223...142,302,224
|
|
Q
|
GWAS1164906_H
|
Testicular Germ Cell Tumor QTL GWAS1164906 (human)
|
|
IAGP
|
rs12699477
| 2.0E-10 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 7:1,929,317...1,929,318
|
|
Q
|
GWAS1164907_H
|
Testicular Germ Cell Tumor QTL GWAS1164907 (human)
|
|
IAGP
|
rs7010162
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 8:70,064,270...70,064,271
|
|
Q
|
GWAS1164908_H
|
Testicular Germ Cell Tumor QTL GWAS1164908 (human)
|
|
IAGP
|
rs7040024
| 1.0E-32 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 9:845,516...845,517
|
|
Q
|
GWAS1164909_H
|
Testicular Germ Cell Tumor QTL GWAS1164909 (human)
|
|
IAGP
|
rs755383
| 7.0E-41 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 9:863,635...863,636
|
|
Q
|
GWAS1164910_H
|
Testicular Germ Cell Tumor QTL GWAS1164910 (human)
|
|
IAGP
|
rs7107174
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr11:78,286,890...78,286,891
|
|
Q
|
GWAS1164911_H
|
Testicular Germ Cell Tumor QTL GWAS1164911 (human)
|
|
IAGP
|
rs2900333
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr12:14,500,933...14,500,934
|
|
Q
|
GWAS1164912_H
|
Testicular Germ Cell Tumor QTL GWAS1164912 (human)
|
|
IAGP
|
rs3782181
| 1.0E-76 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr12:88,559,784...88,559,785
|
|
Q
|
GWAS1164913_H
|
Testicular Germ Cell Tumor QTL GWAS1164913 (human)
|
|
IAGP
|
rs4888262
| 6.0E-11 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr16:74,636,560...74,636,561
|
|
Q
|
GWAS1164914_H
|
Testicular Germ Cell Tumor QTL GWAS1164914 (human)
|
|
IAGP
|
rs55637647
| 1.0E-7 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr16:88,482,856...88,482,857
|
|
Q
|
GWAS1164915_H
|
Testicular Germ Cell Tumor QTL GWAS1164915 (human)
|
|
IAGP
|
rs7501939
| 1.0E-14 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr17:37,741,165...37,741,166
|
|
Q
|
GWAS1164916_H
|
Testicular Germ Cell Tumor QTL GWAS1164916 (human)
|
|
IAGP
|
rs2195987
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr19:23,966,743...23,966,744
|
|
Q
|
GWAS1171675_H
|
Testicular Germ Cell Tumor QTL GWAS1171675 (human)
|
|
IAGP
|
rs6927322
| 6.0E-6 |
|
|
GWAS_CATALOG |
PMID:26503584 |
|
NCBI chr 6:31,121,204...31,121,205
|
|
Q
|
GWAS1171676_H
|
Testicular Germ Cell Tumor QTL GWAS1171676 (human)
|
|
IAGP
|
rs147686985
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:26503584 |
|
NCBI chr 3:167,011,129...167,011,130
|
|
Q
|
GWAS1171677_H
|
Testicular Germ Cell Tumor QTL GWAS1171677 (human)
|
|
IAGP
|
rs11705932
| 2.0E-9 |
|
|
GWAS_CATALOG |
PMID:26503584 |
|
NCBI chr 3:142,100,008...142,100,009
|
|
Q
|
GWAS1171678_H
|
Testicular Germ Cell Tumor QTL GWAS1171678 (human)
|
|
IAGP
|
rs7107174
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:26503584 |
|
NCBI chr11:78,286,890...78,286,891
|
|
Q
|
GWAS1453779_H
|
Testicular Germ Cell Tumor QTL GWAS1453779 (human)
|
|
IAGP
|
rs3790672
| 2.0E-7 |
|
|
GWAS_CATALOG |
PMID:25877299 |
|
NCBI chr 1:165,904,155...165,904,156
|
|
Q
|
GWAS1453780_H
|
Testicular Germ Cell Tumor QTL GWAS1453780 (human)
|
|
IAGP
|
rs9905704
| 4.0E-6 |
|
|
GWAS_CATALOG |
PMID:25877299 |
|
NCBI chr17:58,555,182...58,555,183
|
|
Q
|
GWAS1453781_H
|
Testicular Germ Cell Tumor QTL GWAS1453781 (human)
|
|
IAGP
|
rs2839186
| 3.0E-6 |
|
|
GWAS_CATALOG |
PMID:25877299 |
|
NCBI chr21:46,270,154...46,270,155
|
|
Q
|
GWAS1482933_H
|
Testicular Germ Cell Tumor QTL GWAS1482933 (human)
|
|
IAGP
|
rs4561483
| 4.0E-7 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr16:11,826,180...11,826,181
|
|
Q
|
GWAS1482934_H
|
Testicular Germ Cell Tumor QTL GWAS1482934 (human)
|
|
IAGP
|
rs8046148
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr16:50,109,033...50,109,034
|
|
Q
|
GWAS1482935_H
|
Testicular Germ Cell Tumor QTL GWAS1482935 (human)
|
|
IAGP
|
rs9905704
| 2.0E-14 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr17:58,555,182...58,555,183
|
|
Q
|
GWAS1482936_H
|
Testicular Germ Cell Tumor QTL GWAS1482936 (human)
|
|
IAGP
|
rs3755605
| 4.0E-9 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 3:170,038,331...170,038,332
|
|
Q
|
GWAS1482937_H
|
Testicular Germ Cell Tumor QTL GWAS1482937 (human)
|
|
IAGP
|
rs60180747
| 1.0E-10 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr15:66,370,923...66,370,924
|
|
Q
|
GWAS1482938_H
|
Testicular Germ Cell Tumor QTL GWAS1482938 (human)
|
|
IAGP
|
rs58521262
| 5.0E-14 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr19:23,022,382...23,022,383
|
|
Q
|
GWAS1482939_H
|
Testicular Germ Cell Tumor QTL GWAS1482939 (human)
|
|
IAGP
|
rs34601376
| 2.0E-11 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr19:23,868,026...23,868,027
|
|
Q
|
GWAS1482940_H
|
Testicular Germ Cell Tumor QTL GWAS1482940 (human)
|
|
IAGP
|
rs3790672
| 2.0E-14 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 1:165,904,155...165,904,156
|
|
Q
|
GWAS1482941_H
|
Testicular Germ Cell Tumor QTL GWAS1482941 (human)
|
|
IAGP
|
rs2736100
| 8.0E-20 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 5:1,286,401...1,286,402
|
|
Q
|
GWAS1482942_H
|
Testicular Germ Cell Tumor QTL GWAS1482942 (human)
|
|
IAGP
|
rs210138
| 3.0E-34 |
|
|
GWAS_CATALOG |
PMID:28604732 |
|
NCBI chr 6:33,574,761...33,574,762
|
|
Q
|
GWAS1485393_H
|
Testicular Germ Cell Tumor QTL GWAS1485393 (human)
|
|
IAGP
|
rs4240895
| 6.0E-13 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 1:9,653,328...9,653,329
|
|
Q
|
GWAS1485394_H
|
Testicular Germ Cell Tumor QTL GWAS1485394 (human)
|
|
IAGP
|
rs3790672
| 5.0E-11 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 1:165,904,155...165,904,156
|
|
Q
|
GWAS1485395_H
|
Testicular Germ Cell Tumor QTL GWAS1485395 (human)
|
|
IAGP
|
rs2736100
| 9.0E-25 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 5:1,286,401...1,286,402
|
|
Q
|
GWAS1485396_H
|
Testicular Germ Cell Tumor QTL GWAS1485396 (human)
|
|
IAGP
|
rs210138
| 4.0E-37 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 6:33,574,761...33,574,762
|
|
Q
|
GWAS1485397_H
|
Testicular Germ Cell Tumor QTL GWAS1485397 (human)
|
|
IAGP
|
rs17689040
| 3.0E-11 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr 7:40,880,714...40,880,715
|
|
Q
|
GWAS1485398_H
|
Testicular Germ Cell Tumor QTL GWAS1485398 (human)
|
|
IAGP
|
rs7315956
| 9.0E-10 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr12:70,170,085...70,170,086
|
|
Q
|
GWAS1485399_H
|
Testicular Germ Cell Tumor QTL GWAS1485399 (human)
|
|
IAGP
|
rs4561483
| 6.0E-7 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr16:11,826,180...11,826,181
|
|
Q
|
GWAS1485400_H
|
Testicular Germ Cell Tumor QTL GWAS1485400 (human)
|
|
IAGP
|
rs8046148
| 5.0E-7 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr16:50,109,033...50,109,034
|
|
Q
|
GWAS1485401_H
|
Testicular Germ Cell Tumor QTL GWAS1485401 (human)
|
|
IAGP
|
rs9905704
| 3.0E-20 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr17:58,555,182...58,555,183
|
|
Q
|
GWAS1485402_H
|
Testicular Germ Cell Tumor QTL GWAS1485402 (human)
|
|
IAGP
|
rs9966612
| 4.0E-10 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr18:649,311...649,312
|
|
Q
|
GWAS1485403_H
|
Testicular Germ Cell Tumor QTL GWAS1485403 (human)
|
|
IAGP
|
rs2241024
| 1.0E-16 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr19:27,766,485...27,766,486
|
|
Q
|
GWAS1485404_H
|
Testicular Germ Cell Tumor QTL GWAS1485404 (human)
|
|
IAGP
|
rs2839186
| 7.0E-12 |
|
|
GWAS_CATALOG |
PMID:28604728 |
|
NCBI chr21:46,270,154...46,270,155
|
|
Q
|
GWAS1535157_H
|
Testicular Germ Cell Tumor QTL GWAS1535157 (human)
|
|
IAGP
|
rs4561483
| 2.0E-8 |
|
|
GWAS_CATALOG |
PMID:26503584 |
|
NCBI chr16:11,826,180...11,826,181
|
|
Q
|
GWAS650776_H
|
Testicular Germ Cell Tumor QTL GWAS650776 (human)
|
|
IAGP
|
rs2072499
| 3.0E-7 |
|
|
GWAS_CATALOG |
PMID:25877299 |
|
NCBI chr 1:156,199,819...156,199,820
|
|
Q
|
GWAS691088_H
|
Testicular Germ Cell Tumor QTL GWAS691088 (human)
|
|
IAGP
|
rs2720460
| 6.0E-12 |
|
|
GWAS_CATALOG |
PMID:25877299 |
|
NCBI chr 4:103,133,529...103,133,530
|
|
Q
|
GWAS691305_H
|
Testicular Germ Cell Tumor QTL GWAS691305 (human)
|
|
IAGP
|
rs10510452
| 3.0E-9 |
|
|
GWAS_CATALOG |
PMID:25877299 |
|
NCBI chr 3:16,583,541...16,583,542
|
|
Q
|
GWAS730392_H
|
Testicular Germ Cell Tumor QTL GWAS730392 (human)
|
|
IAGP
|
rs7501939
| 1.0E-9 |
|
|
GWAS_CATALOG |
PMID:25877299 |
|
NCBI chr17:37,741,165...37,741,166
|
|
Q
|
GWAS787759_H
|
Testicular Germ Cell Tumor QTL GWAS787759 (human)
|
|
IAGP
|
rs2195987
| 3.0E-8 |
|
|
GWAS_CATALOG |
PMID:25877299 |
|
NCBI chr19:23,966,743...23,966,744
|
|
Term paths to the root
|